<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34419773</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2212-4934</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Advances in biological regulation</Title><ISOAbbreviation>Adv Biol Regul</ISOAbbreviation></Journal><ArticleTitle>Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?</ArticleTitle><Pagination><StartPage>100820</StartPage><MedlinePgn>100820</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbior.2021.100820</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2212-4926(21)00036-1</ELocationID><Abstract><AbstractText>The article describes the possible pathophysiological origin of COVID-19 and the crucial role of renin-angiotensin system (RAS), providing several "converging" evidence in support of this hypothesis. SARS-CoV-2 has been shown to initially upregulate ACE2 systemic activity (early phase), which can subsequently induce compensatory responses leading to upregulation of both arms of the RAS (late phase) and consequently to critical, advanced and untreatable stages of COVID-19 disease. The main and initial actors of the process are ACE2 and ADAM17 zinc-metalloproteases, which, initially triggered by SARS-CoV-2 spike proteins, work together in increasing circulating Ang 1-7 and Ang 1-9 peptides and downstream (Mas and Angiotensin type 2 receptors) pathways with anti-inflammatory, hypotensive and antithrombotic activities. During the late phase of severe COVID-19, compensatory secretion of renin and ACE enzymes are subsequently upregulated, leading to inflammation, hypertension and thrombosis, which further sustain ACE2 and ADAM17 upregulation. Based on this hypothesis, COVID-19-phase-specific inhibition of different RAS enzymes is proposed as a pharmacological strategy against COVID-19 and vaccine-induced adverse effects. The aim is to prevent the establishment of positive feedback-loops, which can sustain hyperactivity of both arms of the RAS independently of viral trigger and, in some cases, may lead to Long-COVID syndrome.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Montanari</LastName><ForeName>Mariele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomolecular Sciences, University of Urbino "Carlo Bo", 61029, Urbino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canonico</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomolecular Sciences, University of Urbino "Carlo Bo", 61029, Urbino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordi</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomolecular Sciences, University of Urbino "Carlo Bo", 61029, Urbino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandini</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical Pathology, ASUR Marche AV1, Urbino, PU, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barocci</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Pathology, ASUR Marche AV1, Urbino, PU, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benedetti</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomolecular Sciences, University of Urbino "Carlo Bo", 61029, Urbino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlotti</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Prevention, ASUR Marche AV1, Urbino, PU, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamai</LastName><ForeName>Loris</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomolecular Sciences, University of Urbino "Carlo Bo", 61029, Urbino, Italy; INFN-Gran Sasso National Laboratory, Assergi, 67100, L', Aquila, Italy. Electronic address: loris.zamai@uniurb.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Adv Biol Regul</MedlineTA><NlmUniqueID>101572336</NlmUniqueID><ISSNLinking>2212-4926</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C506331">angiotensin I (1-9)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>9041-90-1</RegistryNumber><NameOfSubstance UI="D000803">Angiotensin I</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.86</RegistryNumber><NameOfSubstance UI="D000072198">ADAM17 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.86</RegistryNumber><NameOfSubstance UI="C000606462">ADAM17 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>IJ3FUK8MOF</RegistryNumber><NameOfSubstance UI="C118790">angiotensin I (1-7)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000072198" MajorTopicYN="N">ADAM17 Protein</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000803" MajorTopicYN="N">Angiotensin I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015971" MajorTopicYN="N">Gene Expression Regulation, Enzymologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012084" MajorTopicYN="Y">Renin-Angiotensin System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADAM17</Keyword><Keyword MajorTopicYN="N">RAS inhibitors</Keyword><Keyword MajorTopicYN="N">Renin-angiotensin system</Keyword><Keyword MajorTopicYN="N">Spike N-Terminal domain</Keyword><Keyword MajorTopicYN="N">Zinc-chelating agents</Keyword><Keyword MajorTopicYN="N">Zinc-metalloproteases</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>22</Day><Hour>20</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34419773</ArticleId><ArticleId IdType="pmc">PMC8359569</ArticleId><ArticleId IdType="doi">10.1016/j.jbior.2021.100820</ArticleId><ArticleId IdType="pii">S2212-4926(21)00036-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abassi Z., Skorecki K., Hamo-Giladi D.B., Kruzel-Davila E., Heyman S.N. Kinins and chymase: the forgotten components of the renin-angiotensin system and their implications in COVID-19 disease. Am. J. Physiol. Lung Cell Mol. Physiol. 2021 doi: 10.1152/AJPLUNG.00548.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/AJPLUNG.00548.2020</ArticleId><ArticleId IdType="pmc">PMC7938643</ArticleId><ArticleId IdType="pubmed">33404363</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrati C., Sacchi A., Bordoni V., Cimini E., Notari S., Grassi G., Casetti R., Tartaglia E., Lalle E., D'Abramo A., Castilletti C., Marchioni L., Shi Y., Mariano A., Song J.W., Zhang J.Y., Wang F.S., Zhang C., Fimia G.M., Capobianchi M.R., Piacentini M., Antinori A., Nicastri E., Maeurer M., Zumla A., Ippolito G. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) Cell Death Differ. 2020;27:3196&#x2013;3207. doi: 10.1038/s41418-020-0572-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-0572-6</ArticleId><ArticleId IdType="pmc">PMC7278239</ArticleId><ArticleId IdType="pubmed">32514047</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Shamlan F., El-Hashim A.Z. Bradykinin sensitizes the cough reflex via a B2 receptor dependent activation of TRPV1 and TRPA1 channels through metabolites of cyclooxygenase and 12-lipoxygenase. Respir. Res. 2019;20 doi: 10.1186/s12931-019-1060-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1060-8</ArticleId><ArticleId IdType="pmc">PMC6551914</ArticleId><ArticleId IdType="pubmed">31170972</ArticleId></ArticleIdList></Reference><Reference><Citation>Amiral J. Can COVID-19 induce an autoimmune disease associated with long-lasting symptoms and delayed complications? Ann. Clin. Immunol. Microbiol. 2020;2:1014.</Citation></Reference><Reference><Citation>Anguiano L., Riera M., Pascual J., Valdivielso J.M., Barrios C., Betriu A., Mojal S., Fern&#xe1;ndez E., Soler M.J., Faura A., Castro E., Mar&#xed;a V., Mol&#xed; T., Soria M., Aladr&#xe9;n Regidor M.J., Almirall J., Ponz E., Arteaga Coloma J., Bajo Rubio M.A., Belart Rodr&#xed;guez M., Bielsa-Garc&#xed;a S., Bover Sanjuan J., Bronsoms Artero J., Cabezuelo Romero J.B., Muray Cases S., Calvi&#xf1;o Varela J., Caro Acevedo P., Carreras Bassa J., Cases Amen&#xf3;s A., Mass&#xf3; Jim&#xe9;nez E., Castilla P&#xe9;rez J., Cigarr&#xe1;n Guldris S., L&#xf3;pez Prieto S., Comas Mongay L., Comerma I., Compte Jov&#xe9; M.T., Cuberes Izquierdo M., De &#xc1;lvaro F., Hevia Ojanguren C., De Arriba De La Fuente G., Del Pino Pino M.D., Diaz-Tejeiro Izquierdo R., Dotori M., Duarte V., Estupi&#xf1;an Torres S., Fern&#xe1;ndez Reyes M.J., Fern&#xe1;ndez Rodr&#xed;guez M.L., Fern&#xe1;ndez G., Gal&#xe1;n Serrano A., Garc&#xed;a Cant&#xf3;n C., Garc&#xed;a Herrera A.L., Garc&#xed;a Mena M., Gil Sacaluga L., Aguilar M., G&#xf3;rriz J.L., Huarte Loza E., Lerma J.L., Liebana Ca&#xf1;ada A., Mar&#xed;n &#xc1;lvarez J.P., Mart&#xed;n Alemany N., Mart&#xed;n Garc&#xed;a J., Mart&#xed;nez Castelao A., Mart&#xed;nez Villaescusa M., Mart&#xed;nez I., Moina Eguren I., Moreno Los Huertos S., Mouzo Mirco R., Munar Vila A., Mu&#xf1;oz D&#xed;az A.B., Navarro Gonz&#xe1;lez J.F., Nieto J., Carre&#xf1;o A., Novoa Fern&#xe1;ndez E., Ortiz A., Fernandez B., Para&#xed;so V., P&#xe9;rez Font&#xe1;n M., Peris Domingo A., Pi&#xf1;era Haces C., Prados Garrido M.D., Prieto Velasco M., Puig Mar&#xed; C., Rivera Gorr&#xed;n M., Rubio E., Ruiz P., Salgueira Lazo M., Mart&#xed;nez Puerto A.I., S&#xe1;nchez Tomero J.A., S&#xe1;nchez J.E., Sans Lorman R., Saracho R., Sarrias M., Prat O., Sousa F., Toran D., Tornero Molina F., Us&#xf3;n Carrasco J.J., Valera Cortes I., Vilaprinyo Del Perugia M.M., Virto Ruiz R.C. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease. Nephrol. Dial. Transplant. 2015;30:1176&#x2013;1185. doi: 10.1093/ndt/gfv025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfv025</ArticleId><ArticleId IdType="pmc">PMC7107869</ArticleId><ArticleId IdType="pubmed">25813276</ArticleId></ArticleIdList></Reference><Reference><Citation>Awasthi M., Gulati S., Sarkar D.P., Tiwari S., Kateriya S., Ranjan P., Verma S.K. 2020. The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV. Viruses 12.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12090909</ArticleId><ArticleId IdType="pmc">PMC7551769</ArticleId><ArticleId IdType="pubmed">32825063</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Jan Thibaut H., Hurdiss D.L., Wahedi M., Van Vliet A.L.W., Van Kuppeveld F.J.M. Identification of the cell-surface protease adam9 as an entry factor for encephalomyocarditis virus. mBio. 2019;10 doi: 10.1128/mBio.01780-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01780-19</ArticleId><ArticleId IdType="pmc">PMC6692517</ArticleId><ArticleId IdType="pubmed">31409686</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandsma R.H.J., Van Goor H., Yourshaw M., Horlings R.K., Jonkman M.F., Sch&#xf6;lvinck E.H., Karrenbeld A., Scheenstra R., K&#xf6;mhoff M., Rump P., Koopman-Keemink Y., Nelson S.F., Escher J.C., Cutz E., Mart&#xed;n M.G. Loss of ADAM17 is associated with severe multiorgan dysfunction. Hum. Pathol. 2015;46:923&#x2013;928. doi: 10.1016/j.humpath.2015.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2015.02.010</ArticleId><ArticleId IdType="pmc">PMC6044207</ArticleId><ArticleId IdType="pubmed">25804906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bean D.M., Kraljevic Z., Searle T., Bendayan R., Kevin O., Pickles A., Folarin A., Roguski L., Noor K., Shek A., Zakeri R., Shah A.M., Teo J.T., Dobson R.J. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust. Eur. J. Heart Fail. 2020;22:967&#x2013;974. doi: 10.1002/ejhf.1924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1924</ArticleId><ArticleId IdType="pmc">PMC7301045</ArticleId><ArticleId IdType="pubmed">32485082</ArticleId></ArticleIdList></Reference><Reference><Citation>Belizna C., Pregnolato F., Abad S., Alijotas-Reig J., Amital H., Amoura Z., Andreoli L., Andres E., Aouba A., Apras Bilgen S., Arnaud L., Bienvenu B., Bitsadze V., Blanco P., Blank M., Borghi M.O., Caligaro A., Candrea E., Canti V., Chiche L., Chretien J.M., Cohen Tervaert J.W., Damian L., Delross T., Dernis E., Devreese K., Djokovic A., Esteve-Valverde E., Favaro M., Fassot C., Ferrer-Oliveras R., Godon A., Hamidou M., Hasan M., Henrion D., Imbert B., Jeandel P.Y., Jeannin P., Jego P., Jourde-Chiche N., Khizroeva J., Lambotte O., Landron C., Latino J.O., Lazaro E., de Leeuw K., Le Gallou T., Kili&#xe7; L., Limper M., Loufrani L., Lubin R., Magy-Bertrand N., Mahe G., Makatsariya A., Martin T., Muchardt C., Nagy G., Omarjee L., Van Paasen P., Pernod G., Perrinet F., P&#xef;res Rosa G., Pistorius M.A., Ruffatti A., Said F., Saulnier P., Sene D., Sentilhes L., Shovman O., Sibilia J., Sinescu C., Stanisavljevic N., Stojanovich L., Tam L.S., Tincani A., Tollis F., Udry S., Ungeheuer M.N., Versini M., Cervera R., Meroni P.L. HIBISCUS: hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome. Autoimmun. Rev. 2018 doi: 10.1016/j.autrev.2018.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.05.012</ArticleId><ArticleId IdType="pubmed">30316994</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee S., Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr. Clin. Med. 2020;2:2048&#x2013;2058. doi: 10.1007/s42399-020-00521-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00521-8</ArticleId><ArticleId IdType="pmc">PMC7501509</ArticleId><ArticleId IdType="pubmed">32984764</ArticleId></ArticleIdList></Reference><Reference><Citation>Binder C., Poglitsch M., Agibetov A., Duca F., Zotter-Tufaro C., Nitsche C., Aschauer S., Kammerlander A.A., Oeztuerk B., Hengstenberg C., Mascherbauer J., Bonderman D. Angs (angiotensins) of the alternative renin-angiotensin system predict outcome in patients with heart failure and preserved ejection fraction. Hypertension. 2019;74:285&#x2013;294. doi: 10.1161/HYPERTENSIONAHA.119.12786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.119.12786</ArticleId><ArticleId IdType="pubmed">31230551</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B.E., Liu W.C., Uhl S., Hoagland D., M&#xf8;ller R., Jordan T.X., Oishi K., Panis M., Sachs D., Wang T.T., Schwartz R.E., Lim J.K., Albrecht R.A., tenOever B.R. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036&#x2013;1045. doi: 10.1016/j.cell.2020.04.026. e9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaydon D.C., Biancheri P., Di W.-L., Plagnol V., Cabral R.M., Brooke M.A., van Heel D.A., Ruschendorf F., Toynbee M., Walne A., O'Toole E.A., Martin J.E., Lindley K., Vulliamy T., Abrams D.J., MacDonald T.T., Harper J.I., Kelsell D.P. Inflammatory skin and bowel disease linked to ADAM17 deletion. N. Engl. J. Med. 2011;365:1502&#x2013;1508. doi: 10.1056/nejmoa1100721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1100721</ArticleId><ArticleId IdType="pubmed">22010916</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleidorn J., Alamzad-Krabbe H., Gerhards B., Kraus T., Brand P., Krabbe J., Martin C. The pro-inflammatory stimulus of zinc- and copper-containing welding fumes in whole blood assay via protein tyrosine phosphatase 1B inhibition. Sci. Rep. 2019;9 doi: 10.1038/s41598-018-37803-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-37803-0</ArticleId><ArticleId IdType="pmc">PMC6362009</ArticleId><ArticleId IdType="pubmed">30718726</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosso M., Thanaraj T.A., Abu-Farha M., Alanbaei M., Abubaker J., Al-Mulla F. The two faces of ACE2: the role of ACE2 receptor and its polymorphisms in hypertension and COVID-19. Mol. Ther. - Methods Clin. Dev. 2020 doi: 10.1016/j.omtm.2020.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2020.06.017</ArticleId><ArticleId IdType="pmc">PMC7314689</ArticleId><ArticleId IdType="pubmed">32665962</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J.D. Antihypertensive drugs and risk of COVID-19? Lancet Respir. Med. 2020 doi: 10.1016/S2213-2600(20)30158-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30158-2</ArticleId><ArticleId IdType="pmc">PMC7194728</ArticleId><ArticleId IdType="pubmed">32222168</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell L.M., Risvanis J., Kubota E., Dean R.G., MacDonald P.S., Lu S., Tikellis C., Grant S.L., Lew R.A., Smith A.I., Cooper M.E., Johnston C.I. Myocardial infarction increases ACE2 expression in rat and humans. Eur. Heart J. 2005;26:369&#x2013;375. doi: 10.1093/eurheartj/ehi114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehi114</ArticleId><ArticleId IdType="pubmed">15671045</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes J.J., Gross S., Ellard C., Connolly K., Donahue S., Picarella D. Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice. Inflamm. Res. 2009;58:819&#x2013;827. doi: 10.1007/s00011-009-0053-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-009-0053-3</ArticleId><ArticleId IdType="pubmed">19517214</ArticleId></ArticleIdList></Reference><Reference><Citation>Calligaris M., Cuffaro D., Bonelli S., Span&#xf2; D.P., Rossello A., Nuti E., Scilabra S.D. Strategies to target ADAM17 in disease: from its discovery to the iRhom revolution. Mol. 2021. 2021;26 doi: 10.3390/MOLECULES26040944. Page 944 26, 944.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/MOLECULES26040944</ArticleId><ArticleId IdType="pmc">PMC7916773</ArticleId><ArticleId IdType="pubmed">33579029</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., Smura T., Levanov L., Szirovicza L., Tobi A., Kallio-Kokko H., &#xd6;sterlund P., Joensuu M., Meunier F.A., Butcher S.J., Winkler M.S., Mollenhauer B., Helenius A., Gokce O., Teesalu T., Hepojoki J., Vapalahti O., Stadelmann C., Balistreri G., Simons M. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370 doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Carithers L.J., Moore H.M. The genotype-tissue expression (GTEx) project. Biopreserv. Biobanking. 2015 doi: 10.1089/bio.2015.29031.hmm.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bio.2015.29031.hmm</ArticleId><ArticleId IdType="pmc">PMC4692118</ArticleId><ArticleId IdType="pubmed">26484569</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpagnano G.E., Di Lecce V., Quaranta V.N., Zito A., Buonamico E., Capozza E., Palumbo A., Di Gioia G., Valerio V.N., Resta O. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J. Endocrinol. Invest. 2021;44:765&#x2013;771. doi: 10.1007/s40618-020-01370-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01370-x</ArticleId><ArticleId IdType="pmc">PMC7415009</ArticleId><ArticleId IdType="pubmed">32772324</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen L., Thiemann D.R., Andrade F., Trejo Zambrano M.I., Hooper J.E., Leonard E., Spangler J., Cox A.L., Machamer C., Sauer L., Laeyendecker O., Garibaldi B.T., Ray S.C., Mecoli C., Christopher-Stine L., Gutierrez-Alamillo L., Yang Q., Hines D., Clarke W., Rothman R.E., Pekosz A., Fenstermacher K., Wang Z., Zeger S.L., Rosen A. IgM autoantibodies recognizing ACE2 are associated with severe COVID-19. medRxiv Prepr. Serv. Heal. Sci. 2020 doi: 10.1101/2020.10.13.20211664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.13.20211664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan C.K., Huang Y.S., Liao H.W., Tsai I.J., Sun C.Y., Pan H.C., Chueh J.S., Wang J.T., Wu V.C., Chu T.S. Renin-angiotensin-aldosterone system inhibitors and risks of severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Hypertension. 2020;76:1563&#x2013;1571. doi: 10.1161/HYPERTENSIONAHA.120.15989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15989</ArticleId><ArticleId IdType="pmc">PMC7485525</ArticleId><ArticleId IdType="pubmed">32869673</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi X., Yan R., Zhang Jun, Zhang G., Zhang Y., Hao M., Zhang Z., Fan P., Dong Y., Yang Y., Chen Z., Guo Y., Zhang Jinlong, Li Y., Song X., Chen Y., Xia L., Fu L., Hou L., Xu J., Yu C., Li J., Zhou Q., Chen W. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science. 2020;369:650&#x2013;655. doi: 10.1126/science.abc6952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6952</ArticleId><ArticleId IdType="pmc">PMC7319273</ArticleId><ArticleId IdType="pubmed">32571838</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua R.L., Lukassen S., Trump S., Hennig B.P., Wendisch D., Pott F., Debnath O., Th&#xfc;rmann L., Kurth F., V&#xf6;lker M.T., Kazmierski J., Timmermann B., Twardziok S., Schneider S., Machleidt F., M&#xfc;ller-Redetzky H., Maier M., Krannich A., Schmidt S., Balzer F., Liebig J., Loske J., Suttorp N., Eils J., Ishaque N., Liebert U.G., von Kalle C., Hocke A., Witzenrath M., Goffinet C., Drosten C., Laudi S., Lehmann I., Conrad C., Sander L.E., Eils R. COVID-19 severity correlates with airway epithelium&#x2013;immune cell interactions identified by single-cell analysis. Nat. Biotechnol. 2020;38:970&#x2013;979. doi: 10.1038/s41587-020-0602-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0602-4</ArticleId><ArticleId IdType="pubmed">32591762</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke N.E., Fisher M.J., Porter K.E., Lambert D.W., Turner A.J. Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling. PloS One. 2012;7:34747. doi: 10.1371/journal.pone.0034747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034747</ArticleId><ArticleId IdType="pmc">PMC3327712</ArticleId><ArticleId IdType="pubmed">22523556</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke N.E., Belyaev N.D., Lambert D.W., Turner A.J. Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress. Clin. Sci. 2014;126:507&#x2013;516. doi: 10.1042/CS20130291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20130291</ArticleId><ArticleId IdType="pubmed">24147777</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.B., Hanff T.C., William P., Sweitzer N., Rosado-Santander N.R., Medina C., Rodriguez-Mori J.E., Renna N., Chang T.I., Corrales-Medina V., Andrade-Villanueva J.F., Barbagelata A., Cristodulo-Cortez R., D&#xed;az-Cucho O.A., Spaak J., Alfonso C.E., Valdivia-Vega R., Villavicencio-Carranza M., Ayala-Garc&#xed;a R.J., Castro-Callirgos C.A., Gonz&#xe1;lez-Hern&#xe1;ndez L.A., Bernales-Salas E.F., Coacalla-Guerra J.C., Salinas-Herrera C.D., Nicolosi L., Basconcel M., Byrd J.B., Sharkoski T., Bendez&#xfa;-Huasasquiche L.E., Chittams J., Edmonston D.L., Vasquez C.R., Chirinos J.A. Continuation versus discontinuation of renin&#x2013;angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. Lancet Respir. Med. 2021;9:275&#x2013;284. doi: 10.1016/S2213-2600(20)30558-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30558-0</ArticleId><ArticleId IdType="pmc">PMC7832152</ArticleId><ArticleId IdType="pubmed">33422263</ArticleId></ArticleIdList></Reference><Reference><Citation>Coverdale J.P.C., Khazaipoul S., Arya S., Stewart A.J., Blindauer C.A. Crosstalk between zinc and free fatty acids in plasma. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2019 doi: 10.1016/j.bbalip.2018.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2018.09.007</ArticleId><ArticleId IdType="pmc">PMC6372834</ArticleId><ArticleId IdType="pubmed">30266430</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig G.M., Evans S.J., Brayshaw B.J. An inverse relationship between serum zinc and C-reactive protein levels in acutely ill elderly hospital patients. Postgrad. Med. 1990;66:1025&#x2013;1028. doi: 10.1136/pgmj.66.782.1025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.66.782.1025</ArticleId><ArticleId IdType="pmc">PMC2429802</ArticleId><ArticleId IdType="pubmed">2128123</ArticleId></ArticleIdList></Reference><Reference><Citation>Dales N.A., Gould A.E., Brown J.A., Calderwood E.F., Guan B., Minor C.A., Gavin J.M., Hales P., Kaushik V.K., Stewart M., Tummino P.J., Vickers C.S., Ocain T.D., Patane M.A. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J. Am. Chem. Soc. 2002;124:11852&#x2013;11853. doi: 10.1021/ja0277226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja0277226</ArticleId><ArticleId IdType="pubmed">12358520</ArticleId></ArticleIdList></Reference><Reference><Citation>Dancer R.C.A., Parekh D., Lax S., D'Souza V., Zheng S., Bassford C.R., Park D., Bartis D.G., Mahida R., Turner A.M., Sapey E., Wei W., Naidu B., Stewart P.M., Fraser W.D., Christopher K.B., Cooper M.S., Gao F., Sansom D.M., Martineau A.R., Perkins G.D., Thickett D.R. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS) Thorax. 2015;70:617&#x2013;624. doi: 10.1136/thoraxjnl-2014-206680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2014-206680</ArticleId><ArticleId IdType="pmc">PMC4484044</ArticleId><ArticleId IdType="pubmed">25903964</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maat S., De Mast Q., Danser A.H.J., Van De Veerdonk F.L., Maas C. Impaired breakdown of bradykinin and its metabolites as a possible cause for pulmonary edema in COVID-19 infection. Semin. Thromb. Hemost. 2020 doi: 10.1055/s-0040-1712960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1712960</ArticleId><ArticleId IdType="pmc">PMC7645818</ArticleId><ArticleId IdType="pubmed">32526773</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rosa F.G., Palazzo A., Rosso T., Shbaklo N., Mussa M., Boglione L., Borgogno E., Rossati A., Mornese Pinna S., Scabini S., Chichino G., Borr&#xe8; S., Del Bono V., Garavelli P.L., Barill&#xe0; D., Cattel F., Di Perri G., Ciccone G., Lupia T., Corcione S. Risk factors for mortality in COVID-19 hospitalized patients in piedmont, Italy: results from the multicenter, regional, CORACLE registry. J. Clin. Med. 2021;10:1951. doi: 10.3390/jcm10091951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10091951</ArticleId><ArticleId IdType="pmc">PMC8124506</ArticleId><ArticleId IdType="pubmed">34062864</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., Holden K.A., Read J.M., Dondelinger F., Carson G., Merson L., Lee J., Plotkin D., Sigfrid L., Halpin S., Jackson C., Gamble C., Horby P.W., Nguyen-Van-Tam J.S., Ho A., Russell C.D., Dunning J., Openshaw P.J.M., Baillie J.K., Semple M.G. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369 doi: 10.1136/bmj.m1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shennawy L., Hoffmann A.D., Dashzeveg N.K., Mehl P.J., Yu Z., Tokars V.L., Nicolaescu V., Ostiguin C., Jia Y., Li L., Furlong K., Mao C., Wysocki J., Batlle D., Hope T.J., Shen Y., Luo Y., Chae Y., Zhang H., Swaminathan S., Randall G.C., Demonbreun A.R., Ison M.G., Fang D., Liu H. Circulating ACE2-expressing exosomes block SARS-CoV-2 infection as an innate antiviral mechanism. bioRxiv 2020. 2020 doi: 10.1101/2020.12.03.407031. 12.03.407031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.03.407031</ArticleId></ArticleIdList></Reference><Reference><Citation>Epelman S., Shrestha K., Troughton R.W., Francis G.S., Sen S., Klein A.L., Wilson Tang W.H. Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J. Card. Fail. 2009;15:565&#x2013;571. doi: 10.1016/j.cardfail.2009.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2009.01.014</ArticleId><ArticleId IdType="pmc">PMC3179261</ArticleId><ArticleId IdType="pubmed">19700132</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C.E., Miners J.S., Piva G., Willis C.L., Heard D.M., Kidd E.J., Good M.A., Kehoe P.G. 2020. Correction to: ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease. Acta Neuropathol. 2020;139(3):485&#x2013;502. doi: 10.1007/s00401-020-02229-4. 10.1007/s00401-019-02098-6). Acta Neuropathol.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02229-4</ArticleId><ArticleId IdType="pmc">PMC7035243</ArticleId><ArticleId IdType="pubmed">31982938</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 2020 doi: 10.1016/S2213-2600(20)30116-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30116-8</ArticleId><ArticleId IdType="pmc">PMC7118626</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L., Karakiulakis G., Roth M. Antihypertensive drugs and risk of COVID-19? &#x2013; authors' reply. Lancet Respir. Med. 2020 doi: 10.1016/S2213-2600(20)30159-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30159-4</ArticleId><ArticleId IdType="pmc">PMC7194912</ArticleId><ArticleId IdType="pubmed">32222169</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima N., Patel S., Hussain T. Angiotensin AT2 receptor is anti-inflammatory and reno-protective in lipopolysaccharide mice model: role of IL-10. Front. Pharmacol. 2021;12 doi: 10.3389/fphar.2021.600163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.600163</ArticleId><ArticleId IdType="pmc">PMC8082177</ArticleId><ArticleId IdType="pubmed">33935698</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario C.M., Jessup J., Chappell M.C., Averill D.B., Brosnihan K.B., Tallant E.A., Diz D.I., Gallagher P.E. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605&#x2013;2610. doi: 10.1161/CIRCULATIONAHA.104.510461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.510461</ArticleId><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>Fignani D., Licata G., Brusco N., Nigi L., Grieco G.E., Marselli L., Overbergh L., Gysemans C., Colli M.L., Marchetti P., Mathieu C., Eizirik D.L., Sebastiani G., Dotta F. SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic &#x3b2;-cells and in the human pancreas microvasculature. Front. Endocrinol. 2020;11 doi: 10.3389/fendo.2020.596898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.596898</ArticleId><ArticleId IdType="pmc">PMC7691425</ArticleId><ArticleId IdType="pubmed">33281748</ArticleId></ArticleIdList></Reference><Reference><Citation>Foote J.W., Delves H.T. Albumin bound and &#x3b1;2-macroglobulin bound zinc concentrations in the sera of healthy adults. J. Clin. Pathol. 1984;37:1050&#x2013;1054. doi: 10.1136/jcp.37.9.1050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.37.9.1050</ArticleId><ArticleId IdType="pmc">PMC498928</ArticleId><ArticleId IdType="pubmed">6206098</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraga-Silva R.A., Pinheiro S.V.B., Gon&#xe7;alves A.C.C., Alenina N., Bader M., Souza Dos Santos R.A. The antithrombotic effect of angiotensin-(1-7) involves Mas-mediated NO release from platelets. Mol. Med. 2008;14:28&#x2013;35. doi: 10.2119/2007-00073.Fraga-Silva.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/2007-00073.Fraga-Silva</ArticleId><ArticleId IdType="pmc">PMC2078558</ArticleId><ArticleId IdType="pubmed">18026570</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraga-Silva R.A., Sorg B.S., Wankhede M., deDeugd C., Jun J.Y., Baker M.B., Li Y., Castellano R.K., Katovich M.J., Raizada M.K., Ferreira A.J. ACE2 activation promotes antithrombotic activity. Mol. Med. 2010;16:210&#x2013;215. doi: 10.2119/molmed.2009.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2009.00160</ArticleId><ArticleId IdType="pmc">PMC2811560</ArticleId><ArticleId IdType="pubmed">20111697</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchini M., Glingani C., Morandi M., Corghi G., Cerzosimo S., Beduzzi G., Storti A., Di Stasi V., Rastrelli G., Vignozzi L., Mengoli C., Garuti M., Beccaria M., Inglese F., Caruso B., Petilino R.A., Amato M., Nicchio M., Pagani M., Bellani A., Castelli G., Casari S., De Donno G. Safety and efficacy of convalescent plasma in elderly COVID-19 patients: the RESCUE trial. Mayo Clin. Proc. Innov. Qual. Outcomes. 2021;5:403&#x2013;412. doi: 10.1016/j.mayocpiqo.2021.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2021.01.010</ArticleId><ArticleId IdType="pmc">PMC7869678</ArticleId><ArticleId IdType="pubmed">33585799</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M., Burrell L.M., Velkoska E., Griggs K., Angus P.W., Gibson P.R., Lubel J.S. Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: a pilot study. JRAAS - J. Renin-Angiotensin-Aldosterone Syst. 2015;16:559&#x2013;569. doi: 10.1177/1470320314521086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320314521086</ArticleId><ArticleId IdType="pubmed">24505094</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvin M.R., Alvarez C., Miller J.I., Prates E.T., Walker A.M., Amos B.K., Mast A.E., Justice A., Aronow B., Jacobson D. A mechanistic model and therapeutic interventions for covid-19 involving a ras-mediated bradykinin storm. Elife. 2020;9:1&#x2013;16. doi: 10.7554/eLife.59177.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.59177</ArticleId><ArticleId IdType="pmc">PMC7410499</ArticleId><ArticleId IdType="pubmed">32633718</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosal S., Mukherjee J., Sinha B., Gangopadhyay K. 2020. The effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on death and severity of disease in patients with coronavirus disease 2019 (COVID-19): a meta-analysis. medRxiv. 2020 doi: 10.1101/2020.04.23.20076661. 04.23.20076661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.23.20076661</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert B.W., Slechta J. A case of ivermectin-induced warfarin toxicity: first published report. Hosp. Pharm. 2018;53:393&#x2013;394. doi: 10.1177/0018578718758972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0018578718758972</ArticleId><ArticleId IdType="pmc">PMC6293392</ArticleId><ArticleId IdType="pubmed">30559526</ArticleId></ArticleIdList></Reference><Reference><Citation>Glowacka I., Bertram S., Herzog P., Pfefferle S., Steffen I., Muench M.O., Simmons G., Hofmann H., Kuri T., Weber F., Eichler J., Drosten C., P&#xf6;hlmann S. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J. Virol. 2010;84:1198&#x2013;1205. doi: 10.1128/jvi.01248-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01248-09</ArticleId><ArticleId IdType="pmc">PMC2798380</ArticleId><ArticleId IdType="pubmed">19864379</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham C., Seow J., Huettner I., Khan H., Kouphou N., Acors S., Winstone H., Pickering S., Galao R.P., Dupont L., Lista M.J., Jimenez-Guarde&#xf1;o J.M., Laing A.G., Wu Y., Joseph M., Muir L., van Gils M.J., Ng W.M., Duyvesteyn H.M.E., Zhao Y., Bowden T.A., Shankar-Hari M., Rosa A., Cherepanov P., McCoy L.E., Hayday A.C., Neil S.J.D., Malim M.H., Doores K.J. Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant. Immunity. 2021;54:1276&#x2013;1289. doi: 10.1016/j.immuni.2021.03.023. e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.03.023</ArticleId><ArticleId IdType="pmc">PMC8015430</ArticleId><ArticleId IdType="pubmed">33836142</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadi-Alijanvand H., Rouhani M. Studying the effects of ACE2 mutations on the stability, dynamics, and dissociation process of SARS-CoV-2 S1/hACE2 complexes. J. Proteome Res. 2020;19:4609&#x2013;4623. doi: 10.1021/acs.jproteome.0c00348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00348</ArticleId><ArticleId IdType="pubmed">32786692</ArticleId></ArticleIdList></Reference><Reference><Citation>Haga S., Yamamoto Norio, Nakai-Murakami C., Osawa Y., Tokunaga K., Sata T., Yamamoto Naoki, Sasazuki T., Ishizaka Y. Modulation of TNF-&#x3b1;-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-&#x3b1; production and facilitates viral entry. Proc. Natl. Acad. Sci. U.S.A. 2008;105:7809&#x2013;7814. doi: 10.1073/pnas.0711241105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0711241105</ArticleId><ArticleId IdType="pmc">PMC2409424</ArticleId><ArticleId IdType="pubmed">18490652</ArticleId></ArticleIdList></Reference><Reference><Citation>Haga S., Nagata N., Okamura T., Yamamoto Norio, Sata T., Yamamoto Naoki, Sasazuki T., Ishizaka Y. TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds. Antivir. Res. 2010;85:551&#x2013;555. doi: 10.1016/j.antiviral.2009.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.12.001</ArticleId><ArticleId IdType="pmc">PMC7114272</ArticleId><ArticleId IdType="pubmed">19995578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampl V., Herget J., B&#xed;bov&#xe1; J., Banasov&#xe1; A., Huskov&#xe1; Z., Va&#x144;ourkov&#xe1; Z., J&#xed;chov&#xe1; Kujal P., Vernerov&#xe1; Z., Sadowski J., &#x10c;ervenka L. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/g-protein-coupled mas receptor axis attenuates pulmonary hypertension in ren-2 transgenic rats exposed to chronic hypoxia. Physiol. Res. 2015;64:25&#x2013;38. doi: 10.33549/physiolres.932861.</Citation><ArticleIdList><ArticleId IdType="doi">10.33549/physiolres.932861</ArticleId><ArticleId IdType="pubmed">25194138</ArticleId></ArticleIdList></Reference><Reference><Citation>Han D.P., Penn-Nicholson A., Cho M.W. Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology. 2006;350:15&#x2013;25. doi: 10.1016/j.virol.2006.01.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.01.029</ArticleId><ArticleId IdType="pmc">PMC7111894</ArticleId><ArticleId IdType="pubmed">16510163</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassanpour M., Rezaie J., Nouri M., Panahi Y. The role of extracellular vesicles in COVID-19 virus infection. Infect. Genet. Evol. 2020 doi: 10.1016/j.meegid.2020.104422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2020.104422</ArticleId><ArticleId IdType="pmc">PMC7293471</ArticleId><ArticleId IdType="pubmed">32544615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemnes A.R., Rathinasabapathy A., Austin E.A., Brittain E.L., Carrier E.J., Chen X., Fessel J.P., Fike C.D., Fong P., Fortune N., Gerszten R.E., Johnson J.A., Kaplowitz M., Newman J.H., Piana R., Pugh M.E., Rice T.W., Robbins I.M., Wheeler L., Yu C., Loyd J.E., West J. A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. Eur. Respir. J. 2018;51 doi: 10.1183/13993003.02638-2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02638-2017</ArticleId><ArticleId IdType="pmc">PMC6613216</ArticleId><ArticleId IdType="pubmed">29903860</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjorts&#xf8; E., Ovist J., Bud M.I., Thomsen J.L., Andersen J.B., Wiberg-J&#xf8;rgensen F., Jensen N.K., Jones R., Reid L.M., Zapol W.M. ARDS after accidental inhalation of zinc chloride smoke. Intensive Care Med. 1988;14:17&#x2013;24. doi: 10.1007/BF00254116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00254116</ArticleId><ArticleId IdType="pubmed">3278025</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Huentelman M.J., Zubcevic J., Hern&#xe1;ndez Prada J.A., Xiao X., Dimitrov D.S., Raizada M.K., Ostrov D.A. Sructure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor. Hypertension. 2004;44:903&#x2013;906. doi: 10.1161/01.HYP.0000146120.29648.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000146120.29648.36</ArticleId><ArticleId IdType="pubmed">15492138</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunyady L., Catt K.J. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol. 2006 doi: 10.1210/me.2004-0536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2004-0536</ArticleId><ArticleId IdType="pubmed">16141358</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., Yang P., Sarao R., Wada T., Leong-Poi H., Crackower M.A., Fukamizu A., Hui C.C., Hein L., Uhlig S., Slutsky A.S., Jiang C., Penninger J.M. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112&#x2013;116. doi: 10.1038/nature03712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03712</ArticleId><ArticleId IdType="pmc">PMC7094998</ArticleId><ArticleId IdType="pubmed">16001071</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito S., Ansari P., Sakatsume M., Dickensheets H., Vazquez N., Donnelly R.P., Larner A.C., Finbloom D.S. Interleukin-10 inhibits expression of both interferon &#x2013; and interferon &#x3b3;&#x2013; induced genes by suppressing tyrosine phosphorylation of STAT1. Blood. 1999;93:1456&#x2013;1463. doi: 10.1182/blood.v93.5.1456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.v93.5.1456</ArticleId><ArticleId IdType="pubmed">10029571</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H. Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease. Shock. 2016 doi: 10.1097/SHK.0000000000000633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000633</ArticleId><ArticleId IdType="pubmed">27082314</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H.P., Look D.C., Tan P., Shi L., Hickey M., Gakhar L., Chappell M.C., Wohlford-Lenane C., McCray P.B. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am. J. Physiol. Lung Cell Mol. Physiol. 2009;297:84&#x2013;96. doi: 10.1152/ajplung.00071.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00071.2009</ArticleId><ArticleId IdType="pmc">PMC2711803</ArticleId><ArticleId IdType="pubmed">19411314</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi S., Balasubramanian N., Vasam G., Jarajapu Y.P.R. Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cells. Eur. J. Pharmacol. 2016;774:25&#x2013;33. doi: 10.1016/j.ejphar.2016.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2016.01.007</ArticleId><ArticleId IdType="pmc">PMC4804635</ArticleId><ArticleId IdType="pubmed">26851370</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi S., Wollenzien H., Leclerc E., Jarajapu Y.P.R. Hypoxic regulation of angiotensin-converting enzyme 2 and Mas receptor in human CD34+ cells. J. Cell. Physiol. 2019;234:20420&#x2013;20431. doi: 10.1002/jcp.28643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28643</ArticleId><ArticleId IdType="pmc">PMC6660366</ArticleId><ArticleId IdType="pubmed">30989646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinska M., Meyer-Hoffert U., Kantyka T., Potempa J. Kallikreins - the melting pot of activity and function. Biochimie. 2016 doi: 10.1016/j.biochi.2015.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2015.09.023</ArticleId><ArticleId IdType="pmc">PMC4747678</ArticleId><ArticleId IdType="pubmed">26408415</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A., Benthin C., Zeno B., Albertson T.E., Boyd J., Christie J.D., Hall R., Poirier G., Ronco J.J., Tidswell M., Hardes K., Powley W.M., Wright T.J., Siederer S.K., Fairman D.A., Lipson D.A., Bayliffe A.I., Lazaar A.L. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit. Care. 2017;21 doi: 10.1186/s13054-017-1823-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1823-x</ArticleId><ArticleId IdType="pmc">PMC5588692</ArticleId><ArticleId IdType="pubmed">28877748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.A., Yang D., Kida K., Molotkova N., Yeo S.J., Varki N., Iwata M., Dalton N.D., Peterson K.L., Siems W.E., Walther T., Cowling R.T., Kjekshus J., Greenberg B. Effects of ACE2 inhibition in the post-myocardial infarction heart. J. Card. Fail. 2010;16:777&#x2013;785. doi: 10.1016/j.cardfail.2010.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2010.04.002</ArticleId><ArticleId IdType="pmc">PMC2929397</ArticleId><ArticleId IdType="pubmed">20797602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiran Gotru S., van Geffen J.P., Nagy M., Mammadova-Bach E., Eilenberger J., Volz J., Manukjan G., Schulze H., Wagner L., Eber S., Schambeck C., Deppermann C., Brouns S., Nurden P., Greinacher A., Sachs U., Nieswandt B., Hermanns H.M., Heemskerk J.W.M., Braun A. Defective Zn2+ homeostasis in mouse and human platelets with &#x3b1;- and &#x3b4;-storage pool diseases. Sci. Rep. 2019;9 doi: 10.1038/s41598-019-44751-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-44751-w</ArticleId><ArticleId IdType="pmc">PMC6554314</ArticleId><ArticleId IdType="pubmed">31171812</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiseleva A.A., Troisi E.M., Hensley S.E., Kohli R.M., Epstein J.A. SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2. J. Biochem. 2021 doi: 10.1093/jb/mvab041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvab041</ArticleId><ArticleId IdType="pmc">PMC8083718</ArticleId><ArticleId IdType="pubmed">33774672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornilov S.A., Lucas I., Jade K., Dai C.L., Lovejoy J.C., Magis A.T. Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19. Crit. Care. 2020 doi: 10.1186/s13054-020-03141-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03141-9</ArticleId><ArticleId IdType="pmc">PMC7373836</ArticleId><ArticleId IdType="pubmed">32698840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik J.J., Antlanger M., Domenig O., Kaltenecker C.C., Hecking M., Haidinger M., Werzowa J., Saemann C.K.M.D. Molecular regulation of the renin-Angiotensin system in haemodialysis patients. Nephrol. Dial. Transplant. 2015;30:115&#x2013;123. doi: 10.1093/ndt/gfu265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfu265</ArticleId><ArticleId IdType="pubmed">25107336</ArticleId></ArticleIdList></Reference><Reference><Citation>Kragstrup T.W., S&#xf8;gaard Singh H., Grundberg I., Langkilde-Lauesen Nielsen A., Rivellese F., Mehta A., Goldberg M.B., Filbin M., Qvist P., Martin Bibby B., Wenzel Kragstrup T. 2021. Plasma ACE2 levels predict outcome of COVID-19 in hospitalized patients. medRxiv. 2021 doi: 10.1101/2021.03.08.21252819. 03.08.21252819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.08.21252819</ArticleId><ArticleId IdType="pmc">PMC8177449</ArticleId><ArticleId IdType="pubmed">34086837</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer B.K., Ritthaler T., Schweda F., Kees F., Schricker K., Holmer S.R., Kurtz A. Kidney International, Supplement. Nature Publishing Group; 1998. Effects of hypoxia on renin secretion and renal renin gene expression.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1998.06732.x</ArticleId><ArticleId IdType="pubmed">9736275</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramkowski K., Mogielnicki A., Leszczynska A. Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats - PubMed. J. Physiol. Pharmacol. 2010;61:317&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">20610862</ArticleId></ArticleIdList></Reference><Reference><Citation>Krempl C., Schultze B., Laude H., Herrler G. Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus. J. Virol. 1997;71:3285&#x2013;3287. doi: 10.1128/jvi.71.4.3285-3287.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.71.4.3285-3287.1997</ArticleId><ArticleId IdType="pmc">PMC191465</ArticleId><ArticleId IdType="pubmed">9060696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., Bao L., Zhang B., Liu G., Wang Z., Chappell M., Liu Y., Zheng D., Leibbrandt A., Wada T., Slutsky A.S., Liu D., Qin C., Jiang C., Penninger J.M. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 2005;11:875&#x2013;879. doi: 10.1038/nm1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K., Imai Y., Ohto-Nakanishi T., Penninger J.M. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol. Ther. 2010 doi: 10.1016/j.pharmthera.2010.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2010.06.003</ArticleId><ArticleId IdType="pmc">PMC7112678</ArticleId><ArticleId IdType="pubmed">20599443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucharewicz I., Pawlak R., Matys T., Pawlak D., Buczko W. Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7) Hypertension. 2002;40:774&#x2013;779. doi: 10.1161/01.HYP.0000035396.27909.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000035396.27909.40</ArticleId><ArticleId IdType="pubmed">12411476</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;nkel F., Herrler G. Structural and functional analysis of the surface protein of human coronavirus oc43. Virology. 1993;195:195&#x2013;202. doi: 10.1006/viro.1993.1360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1993.1360</ArticleId><ArticleId IdType="pmc">PMC7130786</ArticleId><ArticleId IdType="pubmed">8317096</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriakidis N.C., L&#xf3;pez-Cort&#xe9;s A., Gonz&#xe1;lez E.V., Grimaldos A.B., Prado E.O. 2021. SARS-CoV-2 Vaccines Strategies: a Comprehensive Review of Phase 3 Candidates. npj Vaccines.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-021-00292-w</ArticleId><ArticleId IdType="pmc">PMC7900244</ArticleId><ArticleId IdType="pubmed">33619260</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauw F.N., Pajkrt D., Hack C.E., Kurimoto M., van Deventer S.J.H., van der Poll T. Proinflammatory effects of IL-10 during human endotoxemia. J. Immunol. 2000;165:2783&#x2013;2789. doi: 10.4049/jimmunol.165.5.2783.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.165.5.2783</ArticleId><ArticleId IdType="pubmed">10946310</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavezzo E., Franchin E., Ciavarella C., Cuomo-Dannenburg G., Barzon L., Del Vecchio C., Rossi L., Manganelli R., Loregian A., Navarin N., Abate D., Sciro M., Merigliano S., De Canale E., Vanuzzo M.C., Besutti V., Saluzzo F., Onelia F., Pacenti M., Parisi S.G., Carretta G., Donato D., Flor L., Cocchio S., Masi G., Sperduti A., Cattarino L., Salvador R., Nicoletti M., Caldart F., Castelli G., Nieddu E., Labella B., Fava L., Drigo M., Gaythorpe K.A.M., Ainslie K.E.C., Baguelin M., Bhatt S., Boonyasiri A., Boyd O., Cattarino L., Ciavarella C., Coupland H.L., Cucunub&#xe1; Z., Cuomo-Dannenburg G., Djafaara B.A., Donnelly C.A., Dorigatti I., van Elsland S.L., FitzJohn R., Flaxman S., Gaythorpe K.A.M., Green W.D., Hallett T., Hamlet A., Haw D., Imai N., Jeffrey B., Knock E., Laydon D.J., Mellan T., Mishra S., Nedjati-Gilani G., Nouvellet P., Okell L.C., Parag K.V., Riley S., Thompson H.A., Unwin H.J.T., Verity R., Vollmer M.A.C., Walker P.G.T., Walters C.E., Wang H., Wang Y., Watson O.J., Whittaker C., Whittles L.K., Xi X., Ferguson N.M., Brazzale A.R., Toppo S., Trevisan M., Baldo V., Donnelly C.A., Ferguson N.M., Dorigatti I., Crisanti A. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo&#x2019;. Nature. 2020;584:425&#x2013;429. doi: 10.1038/s41586-020-2488-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2488-1</ArticleId><ArticleId IdType="pubmed">32604404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence A.C., Evin G., Kladis A., Campbell D.J. An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma. J. Hypertens. 1990;8:715&#x2013;724. doi: 10.1097/00004872-199008000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004872-199008000-00005</ArticleId><ArticleId IdType="pubmed">2170511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.J., Cines D.B., Gernsheimer T., Kessler C., Michel M., Tarantino M.D., Semple J.W., Arnold D.M., Godeau B., Lambert M.P., Bussel J.B. Thrombocytopenia following pfizer and moderna SARS-CoV-2 vaccination. Am. J. Hematol. 2021 doi: 10.1002/ajh.26132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26132</ArticleId><ArticleId IdType="pmc">PMC8014568</ArticleId><ArticleId IdType="pubmed">33606296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lew R.A., Warner F.J., Hanchapola I., Yarski M.A., Manohar J., Burrell L.M., Smith A.I. Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp. Physiol. 2008;93:685&#x2013;693. doi: 10.1113/expphysiol.2007.040352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2007.040352</ArticleId><ArticleId IdType="pmc">PMC7197901</ArticleId><ArticleId IdType="pubmed">18223027</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 2016 doi: 10.1146/annurev-virology-110615-042301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-110615-042301</ArticleId><ArticleId IdType="pmc">PMC5457962</ArticleId><ArticleId IdType="pubmed">27578435</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Xu S., Yu M., Wang K., Tao Y., Zhou Y., Shi J., Zhou M., Wu B., Yang Z., Zhang C., Yue J., Zhang Z., Renz H., Liu X., Xie J., Xie M., Zhao J. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J. Allergy Clin. Immunol. 2020;146:110&#x2013;118. doi: 10.1016/j.jaci.2020.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.04.006</ArticleId><ArticleId IdType="pmc">PMC7152876</ArticleId><ArticleId IdType="pubmed">32294485</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Zhang C., Sui J., Kuhn J.H., Moore M.J., Luo S., Wong S.K., Huang I.C., Xu K., Vasilieva N., Murakami A., He Y., Marasco W.A., Guan Y., Choe H., Farzan M. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005;24:1634&#x2013;1643. doi: 10.1038/sj.emboj.7600640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600640</ArticleId><ArticleId IdType="pmc">PMC1142572</ArticleId><ArticleId IdType="pubmed">15791205</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Li J., Hao P., Chen W., Meng X., Li H., Zhang Y., Zhang C., Yang J. Imbalance between angiotensin II and angiotensin-(1-7) in human coronary atherosclerosis. JRAAS - J. Renin-Angiotensin-Aldosterone Syst. 2016;17 doi: 10.1177/1470320316659618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320316659618</ArticleId><ArticleId IdType="pmc">PMC5843867</ArticleId><ArticleId IdType="pubmed">27432541</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.K., Lu Q. Bin, Chen W.W., Xu W., Liu R., Zhang S.F., Du J., Li H., Yao K., Zhai D., Zhang P.H., Xing B., Cui N., Yang Z.D., Yuan C., Zhang X.A., Xu Z., Cao W.C., Hu Z., Liu W. Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome. Sci. Transl. Med. 2018;10 doi: 10.1126/scitranslmed.aat4162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aat4162</ArticleId><ArticleId IdType="pubmed">30232226</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wang X., Chen J., Zhang H., Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in wuhan, China. JAMA Cardiol. 2020;5:825&#x2013;830. doi: 10.1001/jamacardio.2020.1624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1624</ArticleId><ArticleId IdType="pmc">PMC7180726</ArticleId><ArticleId IdType="pubmed">32324209</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zhang Z., Yang L., Lian X., Xie Y., Li S., Xin S., Cao P., Lu J. The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience. 2020;23 doi: 10.1016/j.isci.2020.101160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101160</ArticleId><ArticleId IdType="pmc">PMC7386421</ArticleId><ArticleId IdType="pubmed">32738607</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X., Wang L., Yang C., He J., Wang X., Guo R., Lan A., Dong X., Yang Z., Wang H., Feng J., Ma H. Cyclooxygenase mediates cardioprotection of angiotensin-(1-7) against ischemia/reperfusion-induced injury through the inhibition of oxidative stress. Mol. Med. Rep. 2011;4:1145&#x2013;1150. doi: 10.3892/mmr.2011.570.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2011.570</ArticleId><ArticleId IdType="pubmed">21874245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S., Bae J.H., Kwon H.S., Nauck M.A. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat. Rev. Endocrinol. 2021 doi: 10.1038/s41574-020-00435-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00435-4</ArticleId><ArticleId IdType="pmc">PMC7664589</ArticleId><ArticleId IdType="pubmed">33188364</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C., Datta V., Okwan&#x2010;Duodu D., Chen X., Fuchs S., Alsabeh R., Billet S., Bernstein K.E., Shen X.Z. Angiotensin&#x2010;converting enzyme is required for normal myelopoiesis. Faseb. J. 2011;25:1145&#x2013;1155. doi: 10.1096/fj.10-169433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.10-169433</ArticleId><ArticleId IdType="pmc">PMC3058713</ArticleId><ArticleId IdType="pubmed">21148418</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Huang F., Xu J., Yang P., Qin Y., Cao M., Wang Z., Li X., Zhang S., Ye L., Lv J., Wei J., Xie T., Gao H., Xu K.-F., Wang F., Liu L., Jiang C. Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients. medRxiv 2020. 2020 doi: 10.1101/2020.03.20.20039586. 03.20.20039586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.20.20039586</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Yang Y., Zhang C., Huang F., Wang F., Yuan J., Wang Z., Li Jinxiu, Li Jianming, Feng C., Zhang Z., Wang L., Peng L., Chen L., Qin Y., Zhao D., Tan S., Yin L., Xu J., Zhou C., Jiang C., Liu L. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci. China Life Sci. 2020;63:364&#x2013;374. doi: 10.1007/s11427-020-1643-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1643-8</ArticleId><ArticleId IdType="pmc">PMC7088566</ArticleId><ArticleId IdType="pubmed">32048163</ArticleId></ArticleIdList></Reference><Reference><Citation>Longhitano Y., Racca F., Zanza C., Muncinelli M., Guagliano A., Peretti E., Minerba A.C., Mari M., Boverio R., Salio M., Chichino G., Franceschi F., Piccioni A., Abenavoli L., Salvini M., Artico M. Venous thrombo-embolism in hospitalized sars-cov-2 patients treated with three different anticoagulation protocols: prospective observational study. Biology. 2020;9:1&#x2013;12. doi: 10.3390/biology9100310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology9100310</ArticleId><ArticleId IdType="pmc">PMC7600769</ArticleId><ArticleId IdType="pubmed">32987902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Sun P.D. High affinity binding of SARS-cov-2 spike protein enhances ACE2 carboxypeptidase activity. J. Biol. Chem. 2020;295:18579&#x2013;18588. doi: 10.1074/jbc.RA120.015303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.015303</ArticleId><ArticleId IdType="pmc">PMC7833600</ArticleId><ArticleId IdType="pubmed">33122196</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G., Wang Q., Gao G.F. Bat-to-human: spike features determining &#x201c;host jump&#x201d; of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol. 2015 doi: 10.1016/j.tim.2015.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2015.06.003</ArticleId><ArticleId IdType="pmc">PMC7125587</ArticleId><ArticleId IdType="pubmed">26206723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Zhang H., Dauphars D.J., He Y.W. A potential role of interleukin 10 in COVID-19 pathogenesis. Trends Immunol. 2021 doi: 10.1016/j.it.2020.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.012</ArticleId><ArticleId IdType="pmc">PMC7605819</ArticleId><ArticleId IdType="pubmed">33214057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundstr&#xf6;m A., Ziegler L., Havervall S., Rudberg A.S., von Meijenfeldt F., Lisman T., Mackman N., Sand&#xe9;n P., Th&#xe5;lin C. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers. J. Med. Virol. 2021 doi: 10.1002/jmv.27144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27144</ArticleId><ArticleId IdType="pmc">PMC8426677</ArticleId><ArticleId IdType="pubmed">34138483</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackey K., Kansagara D., Vela K. Update alert 8: risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults. Ann. Intern. Med. 2021;174:W54. doi: 10.7326/l21-0223. &#x2013;W55.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/l21-0223</ArticleId><ArticleId IdType="pmc">PMC8082523</ArticleId><ArticleId IdType="pubmed">33900794</ArticleId></ArticleIdList></Reference><Reference><Citation>Magalhaes G.S., Barroso L.C., Reis A.C., Rodrigues-Machado M.G., Greg&#xf3;rio J.F., Motta-Santos D., Oliveira A.C., Perez D.A., Barcelos L.S., Teixeira M.M., Santos R.A.S., Pinho V., Campagnole-Santos M.J. Angiotensin-(1-7) promotes resolution of eosinophilic inflammation in an experimental model of asthma. Front. Immunol. 2018;9 doi: 10.3389/fimmu.2018.00058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00058</ArticleId><ArticleId IdType="pmc">PMC5797293</ArticleId><ArticleId IdType="pubmed">29434591</ArticleId></ArticleIdList></Reference><Reference><Citation>Masre S.F., Jufri N.F., Ibrahim F.W., Abdul Raub S.H. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy. Rev. Med. Virol. 2020 doi: 10.1002/rmv.2207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2207</ArticleId><ArticleId IdType="pmc">PMC7883063</ArticleId><ArticleId IdType="pubmed">33368788</ArticleId></ArticleIdList></Reference><Reference><Citation>McCallum M., De Marco A., Lempp F.A., Tortorici M.A., Pinto D., Walls A.C., Beltramello M., Chen A., Liu Z., Zatta F., Zepeda S., di Iulio J., Bowen J.E., Montiel-Ruiz M., Zhou J., Rosen L.E., Bianchi S., Guarino B., Fregni C.S., Abdelnabi R., Foo S.Y.C., Rothlauf P.W., Bloyet L.M., Benigni F., Cameroni E., Neyts J., Riva A., Snell G., Telenti A., Whelan S.P.J., Virgin H.W., Corti D., Pizzuto M.S., Veesler D. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021;184:2332&#x2013;2347. doi: 10.1016/j.cell.2021.03.028. e16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.028</ArticleId><ArticleId IdType="pmc">PMC7962585</ArticleId><ArticleId IdType="pubmed">33761326</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy K.R., Rennick L.J., Nambulli S., Robinson-McCarthy L.R., Bain W.G., Haidar G., Paul Duprex W. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science. 2021;371:1139&#x2013;1142. doi: 10.1126/science.abf6950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf6950</ArticleId><ArticleId IdType="pmc">PMC7971772</ArticleId><ArticleId IdType="pubmed">33536258</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng J., Xiao G., Zhang J., He X., Ou M., Bi J., Yang R., Di W., Wang Z., Li Z., Gao H., Liu L., Zhang G. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg. Microb. Infect. 2020 doi: 10.1080/22221751.2020.1746200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1746200</ArticleId><ArticleId IdType="pmc">PMC7170368</ArticleId><ArticleId IdType="pubmed">32228222</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogielnicki A., Chabielska E., Pawlak R., Szemraj J., Buczko W. Angiotensin II enhances thrombosis development in renovascular hypertensive rats. Thromb. Haemostasis. 2005;93:1069&#x2013;1076. doi: 10.1160/TH04-10-0701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH04-10-0701</ArticleId><ArticleId IdType="pubmed">15968390</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogielnicki A., Kramkowski K., Hermanowicz J.M., Leszczynska A., Przyborowski K., Buczko W. Angiotensin-(1-9) enhances stasis-induced venous thrombosis in the rat because of the impairment of fibrinolysis. JRAAS - J. Renin-Angiotensin-Aldosterone Syst. 2014;15:13&#x2013;21. doi: 10.1177/1470320313498631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320313498631</ArticleId><ArticleId IdType="pubmed">23884911</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteil V., Kwon H., Prado P., Hagelkr&#xfc;ys A., Wimmer R.A., Stahl M., Leopoldi A., Garreta E., Hurtado del Pozo C., Prosper F., Romero J.P., Wirnsberger G., Zhang H., Slutsky A.S., Conder R., Montserrat N., Mirazimi A., Penninger J.M. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181:905&#x2013;913. doi: 10.1016/j.cell.2020.04.004. e7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7181998</ArticleId><ArticleId IdType="pubmed">32333836</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore M.J., Dorfman T., Li W., Wong S.K., Li Y., Kuhn J.H., Coderre J., Vasilieva N., Han Z., Greenough T.C., Farzan M., Choe H. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. J. Virol. 2004;78:10628&#x2013;10635. doi: 10.1128/jvi.78.19.10628-10635.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.78.19.10628-10635.2004</ArticleId><ArticleId IdType="pmc">PMC516384</ArticleId><ArticleId IdType="pubmed">15367630</ArticleId></ArticleIdList></Reference><Reference><Citation>Murai I.H., Fernandes A.L., Sales L.P., Pinto A.J., Goessler K.F., Duran C.S.C., Silva C.B.R., Franco A.S., MacEdo M.B., Dalmolin H.H.H., Baggio J., Balbi G.G.M., Reis B.Z., Antonangelo L., Caparbo V.F., Gualano B., Pereira R.M.R. Effect of a single high dose of vitamin D3on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial. JAMA, J. Am. Med. Assoc. 2021;325:1053&#x2013;1060. doi: 10.1001/jama.2020.26848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.26848</ArticleId><ArticleId IdType="pmc">PMC7890452</ArticleId><ArticleId IdType="pubmed">33595634</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy B., Fejes Z., Szentkereszty Z., S&#xfc;t&#x151; R., V&#xe1;rkonyi I., Ajzner &#xc9;., Kappelmayer J., Papp Z., T&#xf3;th A., Fagyas M. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient. Int. J. Infect. Dis. 2021;103:412&#x2013;414. doi: 10.1016/j.ijid.2020.11.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.184</ArticleId><ArticleId IdType="pmc">PMC7689308</ArticleId><ArticleId IdType="pubmed">33249290</ArticleId></ArticleIdList></Reference><Reference><Citation>Narula S., Yusuf S., Chong M., Ramasundarahettige C., Rangarajan S., Bangdiwala S.I., van Eikels M., Leineweber K., Wu A., Pigeyre M., Par&#xe9; G. Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis. Lancet. 2020;396:968&#x2013;976. doi: 10.1016/S0140-6736(20)31964-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31964-4</ArticleId><ArticleId IdType="pmc">PMC7529405</ArticleId><ArticleId IdType="pubmed">33010842</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng K.W., Attig J., Bolland W., Young G.R., Major J., Wrobel A.G., Gamblin S., Wack A., Kassiotis G. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option. Nat. Genet. 2020;52:1294&#x2013;1302. doi: 10.1038/s41588-020-00732-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00732-8</ArticleId><ArticleId IdType="pmc">PMC7610354</ArticleId><ArticleId IdType="pubmed">33077915</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikiforuk A.M., Kuchinski K.S., Twa D.D.W., Lukac C.D., Sbihi H., Basham C.A., Steidl C., Prystajecky N.A., Jassem A.N., Krajden M., Patrick D.M., Sekirov I. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: a cross-sectional study of people tested for COVID-19 in British Columbia, Canada. EBioMedicine. 2021 doi: 10.1016/j.ebiom.2021.103316. 66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103316</ArticleId><ArticleId IdType="pmc">PMC8016616</ArticleId><ArticleId IdType="pubmed">33819740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocaranza M.P., Jalil J.E. Protective role of the ACE2/Ang-(19) axis in cardiovascular remodeling. Int. J. Hypertens. 2012 doi: 10.1155/2012/594361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/594361</ArticleId><ArticleId IdType="pmc">PMC3270559</ArticleId><ArticleId IdType="pubmed">22315665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocaranza M.P., Riquelme J.A., Garc&#xed;a L., Jalil J.E., Chiong M., Santos R.A.S., Lavandero S. Counter-regulatory renin&#x2013;angiotensin system in cardiovascular disease. Nat. Rev. Cardiol. 2020 doi: 10.1038/s41569-019-0244-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0244-8</ArticleId><ArticleId IdType="pmc">PMC7097090</ArticleId><ArticleId IdType="pubmed">31427727</ArticleId></ArticleIdList></Reference><Reference><Citation>Onabajo O.O., Banday A.R., Stanifer M.L., Yan W., Obajemu A., Santer D.M., Florez-Vargas O., Piontkivska H., Vargas J.M., Ring T.J., Kee C., Doldan P., Tyrrell D.L., Mendoza J.L., Boulant S., Prokunina-Olsson L. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat. Genet. 2020;52:1283&#x2013;1293. doi: 10.1038/s41588-020-00731-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00731-9</ArticleId><ArticleId IdType="pmc">PMC9377523</ArticleId><ArticleId IdType="pubmed">33077916</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-P&#xe9;rez J.T., Riera M., Bosch X., De Caralt T.M., Perea R.J., Pascual J., Soler M.J. Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study. PloS One. 2013;8:61695. doi: 10.1371/journal.pone.0061695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061695</ArticleId><ArticleId IdType="pmc">PMC3632515</ArticleId><ArticleId IdType="pubmed">23630610</ArticleId></ArticleIdList></Reference><Reference><Citation>Paizis G., Tikellis C., Cooper M.E., Schembri J.M., Lew R.A., Smith A.I., Shaw T., Warner F.J., Zuilli A., Burrell L.M., Angus P.W. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut. 2005;54:1790&#x2013;1796. doi: 10.1136/gut.2004.062398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2004.062398</ArticleId><ArticleId IdType="pmc">PMC1774784</ArticleId><ArticleId IdType="pubmed">16166274</ArticleId></ArticleIdList></Reference><Reference><Citation>Palau V., Riera M., Soler M.J. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol. Dial. Transplant. 2020;35:1071&#x2013;1072. doi: 10.1093/ndt/gfaa093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfaa093</ArticleId><ArticleId IdType="pmc">PMC7184459</ArticleId><ArticleId IdType="pubmed">32291449</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang X., Cui Y., Zhu Y. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication. Acta Pharmacol. Sin. 2020 doi: 10.1038/s41401-020-0430-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-0430-6</ArticleId><ArticleId IdType="pmc">PMC7313652</ArticleId><ArticleId IdType="pubmed">32581256</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y.J., Walls A.C., Wang Z., Sauer M.M., Li W., Tortorici M.A., Bosch B.J., DiMaio F., Veesler D. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. Nat. Struct. Mol. Biol. 2019;26:1151&#x2013;1157. doi: 10.1038/s41594-019-0334-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0334-7</ArticleId><ArticleId IdType="pmc">PMC7097669</ArticleId><ArticleId IdType="pubmed">31792450</ArticleId></ArticleIdList></Reference><Reference><Citation>Passos-Silva D.G., Verano-Braga T., Santos R.A.S. Angiotensin-(1-7): beyond the cardio-renal actions. Clin. Sci. 2013 doi: 10.1042/CS20120461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20120461</ArticleId><ArticleId IdType="pubmed">23249272</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V.B., Clarke N., Wang Z., Fan D., Parajuli N., Basu R., Putko B., Kassiri Z., Turner A.J., Oudit G.Y. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. J. Mol. Cell. Cardiol. 2014;66:167&#x2013;176. doi: 10.1016/j.yjmcc.2013.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2013.11.017</ArticleId><ArticleId IdType="pubmed">24332999</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S., Rauf A., Khan H., Abu-Izneid T. Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed. Pharmacother. 2017;94:317&#x2013;325. doi: 10.1016/j.biopha.2017.07.091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.07.091</ArticleId><ArticleId IdType="pubmed">28772209</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S.K., Juno J.A., Lee W.S., Wragg K.M., Hogarth P.M., Kent S.J., Burrell L.M. Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences. Eur. Respir. J. 2021;57:2003730. doi: 10.1183/13993003.03730-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03730-2020</ArticleId><ArticleId IdType="pmc">PMC7830336</ArticleId><ArticleId IdType="pubmed">33479113</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D., Howe A., Mee C., Munier L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., Kelleher A.D., Matthews G., Kelleher A. 2021. Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection. medRxiv. 2021 doi: 10.1101/2021.06.01.21257759. 06.01.21257759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.01.21257759</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirola C.J., Sookoian S. Estimation of renin-angiotensin-aldosterone-system (RAAS)-Inhibitor effect on COVID-19 outcome: a meta-analysis. J. Infect. 2020;81:276&#x2013;281. doi: 10.1016/j.jinf.2020.05.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.052</ArticleId><ArticleId IdType="pmc">PMC7255761</ArticleId><ArticleId IdType="pubmed">32474043</ArticleId></ArticleIdList></Reference><Reference><Citation>Plum L.M., Rink L., Hajo H. The essential toxin: impact of zinc on human health. Int. J. Environ. Res. Publ. Health. 2010 doi: 10.3390/ijerph7041342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph7041342</ArticleId><ArticleId IdType="pmc">PMC2872358</ArticleId><ArticleId IdType="pubmed">20617034</ArticleId></ArticleIdList></Reference><Reference><Citation>Pucci F., Bogaerts P., Rooman M. Modeling the molecular impact of sars-cov-2 infection on the renin-angiotensin system. Viruses. 2020;12:1367. doi: 10.3390/v12121367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12121367</ArticleId><ArticleId IdType="pmc">PMC7760740</ArticleId><ArticleId IdType="pubmed">33265982</ArticleId></ArticleIdList></Reference><Reference><Citation>Puray-Chavez M., LaPak K.M., Schrank T.P., Elliott J.L., Bhatt D.P., Agajanian M.J., Jasuja R., Lawson D.Q., Davis K., Rothlauf P.W., Liu Z., Jo H., Lee N., Tenneti K., Eschbach J.E., Mugisha C.S., Cousins E.M., Cloer E.W., Vuong H.R., VanBlargan L.A., Bailey A.L., Gilchuk P., Crowe J.E., Diamond M.S., Hayes D.N., Whelan S.P.J., Horani A., Brody S.L., Goldfarb D., Major M., Ben Kutluay S.B. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. Cell Rep. 2021 doi: 10.1101/2021.03.01.433431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.01.433431</ArticleId><ArticleId IdType="pmc">PMC8220945</ArticleId><ArticleId IdType="pubmed">34214467</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U., Ding M., Tan G., Zhakparov D., Peng Y., Wawrzyniak P., Wang M., Li S., Morita H., Altunbulakli C., Reiger M., Neumann A.U., Lunjani N., Traidl-Hoffmann C., Nadeau K.C., O'Mahony L., Akdis C., Sokolowska M. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy Eur. J. Allergy Clin. Immunol. 2020;75:2829&#x2013;2845. doi: 10.1111/all.14429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14429</ArticleId><ArticleId IdType="pmc">PMC7300910</ArticleId><ArticleId IdType="pubmed">32496587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadori G. 2020. Hypoalbuminemia: an underestimated, vital characteristic of hospitalized COVID-19 positive patients? Hepatoma Res. 2020 doi: 10.20517/2394-5079.2020.43.</Citation><ArticleIdList><ArticleId IdType="doi">10.20517/2394-5079.2020.43</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramchand J., Patel S.K., Srivastava P.M., Farouque O., Burrell L.M. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PloS One. 2018;13 doi: 10.1371/journal.pone.0198144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198144</ArticleId><ArticleId IdType="pmc">PMC5999069</ArticleId><ArticleId IdType="pubmed">29897923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramya K., Suresh R., Kumar H.Y., Kumar B.R.P., Murthy N.B.S. Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules. Bioorg. Med. Chem. 2020;28 doi: 10.1016/j.bmc.2020.115466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2020.115466</ArticleId><ArticleId IdType="pmc">PMC7112834</ArticleId><ArticleId IdType="pubmed">32247750</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy R., Asante I., Liu S., Parikh P., Liebler J., Borok Z., Rodgers K., Baydur A., Louie S.G. Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: a pilot study. PloS One. 2019;14 doi: 10.1371/journal.pone.0213096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0213096</ArticleId><ArticleId IdType="pmc">PMC6405137</ArticleId><ArticleId IdType="pubmed">30845246</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehman S.U., Tabish M. Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs. Clin. Sci. 2020;134:1143&#x2013;1150. doi: 10.1042/CS20200419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200419</ArticleId><ArticleId IdType="pubmed">32442315</ArticleId></ArticleIdList></Reference><Reference><Citation>Reindl-Schwaighofer R., H&#xf6;dlmoser S., Eskandary F., Poglitsch M., Bonderman D., Strassl R., Aberle J.H., Oberbauer R., Zoufaly A., Hecking M. ACE2 elevation in severe COVID-19. Am. J. Respir. Crit. Care Med. 2021 doi: 10.1164/rccm.202101-0142LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202101-0142LE</ArticleId><ArticleId IdType="pmc">PMC8314901</ArticleId><ArticleId IdType="pubmed">33600742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren L., Yu S., Xu W., Overton J.L., Chiamvimonvat N., Thai P.N. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: a meta-analysis. J. Cardiol. 2020;77 doi: 10.1016/j.jjcc.2020.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2020.10.015</ArticleId><ArticleId IdType="pmc">PMC7605745</ArticleId><ArticleId IdType="pubmed">33168337</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds H.R., Adhikari S., Pulgarin C., Troxel A.B., Iturrate E., Johnson S.B., Hausvater A., Newman J.D., Berger J.S., Bangalore S., Katz S.D., Fishman G.I., Kunichoff D., Chen Y., Ogedegbe G., Hochman J.S. Renin&#x2013;angiotensin&#x2013;aldosterone system inhibitors and risk of covid-19. N. Engl. J. Med. 2020;382:2441&#x2013;2448. doi: 10.1056/nejmoa2008975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2008975</ArticleId><ArticleId IdType="pmc">PMC7206932</ArticleId><ArticleId IdType="pubmed">32356628</ArticleId></ArticleIdList></Reference><Reference><Citation>Riccelli M.G., Goldoni M., Poli D., Mozzoni P., Cavallo D., Corradi M. Welding fumes, a risk factor for lung diseases. Int. J. Environ. Res. Publ. Health. 2020 doi: 10.3390/ijerph17072552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17072552</ArticleId><ArticleId IdType="pmc">PMC7177922</ArticleId><ArticleId IdType="pubmed">32276440</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo E. Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action. Naunyn-Schmiedeberg&#x2019;s Arch. Pharmacol. 2020;393:1153&#x2013;1156. doi: 10.1007/s00210-020-01902-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-020-01902-5</ArticleId><ArticleId IdType="pmc">PMC7251046</ArticleId><ArticleId IdType="pubmed">32462282</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues-Machado M.G., Magalh&#xe3;es G.S., Cardoso J.A., Kangussu L.M., Murari A., Caliari M.V., Oliveira M.L., Cara D.C., Noviello M.L.M., Marques F.D., Pereira J.M., Lautner R.Q., Santos R.A.S., Campagnole-Santos M.J. AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma. Br. J. Pharmacol. 2013;170:835&#x2013;846. doi: 10.1111/bph.12318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12318</ArticleId><ArticleId IdType="pmc">PMC3799597</ArticleId><ArticleId IdType="pubmed">23889691</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;hrborn D., Eckel J., Sell H. Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells. FEBS Lett. 2014;588:3870&#x2013;3877. doi: 10.1016/j.febslet.2014.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.08.029</ArticleId><ArticleId IdType="pubmed">25217834</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino F., Amiel S.A., Zimmet P., Alberti G., Bornstein S., Eckel R.H., Mingrone G., Boehm B., Cooper M.E., Chai Z., Del Prato S., Ji L., Hopkins D., Herman W.H., Khunti K., Mbanya J.-C., Renard E. New-onset diabetes in covid-19. N. Engl. J. Med. 2020;383:789&#x2013;790. doi: 10.1056/nejmc2018688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmc2018688</ArticleId><ArticleId IdType="pmc">PMC7304415</ArticleId><ArticleId IdType="pubmed">32530585</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama I.E., Ravera A., Santema B.T., Van Goor H., Ter Maaten J.M., Cleland J.G.F., Rienstra M., Friedrich A.W., Samani N.J., Ng L.L., Dickstein K., Lang C.C., Filippatos G., Anker S.D., Ponikowski P., Metra M., Van Veldhuisen D.J., Voors A.A. Circulating plasma concentrations of angiotensin-converting enzyme 2 inmen and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur. Heart J. 2020;41:1810&#x2013;1817. doi: 10.1093/eurheartj/ehaa373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa373</ArticleId><ArticleId IdType="pmc">PMC7239195</ArticleId><ArticleId IdType="pubmed">32388565</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R.A.S., Ferreira A.J., Verano-Braga T., Bader M. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J. Endocrinol. 2013;216 doi: 10.1530/JOE-12-0341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JOE-12-0341</ArticleId><ArticleId IdType="pubmed">23092879</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T., Kapoor N., Cao Y., Tapp R.J., Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes. Metabol. 2021 doi: 10.1111/dom.14269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14269</ArticleId><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer A.K., Pfaender S., Hagmeyer S., Tarana L., Mattes A.K., Briel F., K&#xfc;ry S., Boeckers T.M., Grabrucker A.M. Characterization of zinc amino acid complexes for zinc delivery in vitro using Caco-2 cells and enterocytes from hiPSC. Biometals. 2017;30:643&#x2013;661. doi: 10.1007/s10534-017-0033-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-017-0033-y</ArticleId><ArticleId IdType="pmc">PMC5646115</ArticleId><ArticleId IdType="pubmed">28717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmaier A.H. The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003 doi: 10.1152/ajpregu.00535.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00535.2002</ArticleId><ArticleId IdType="pubmed">12793984</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;lke S. Induction of interleukin-10 producing dendritic cells as a tool to suppress allergen-specific T helper 2 responses. Front. Immunol. 2018;9 doi: 10.3389/fimmu.2018.00455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00455</ArticleId><ArticleId IdType="pmc">PMC5867300</ArticleId><ArticleId IdType="pubmed">29616018</ArticleId></ArticleIdList></Reference><Reference><Citation>Semenzato L., Botton J., Drouin J., Baricault B., Vabre C., Cuenot F., Penso L., Herlemont P., Sbidian E., Weill A., Dray-Spira R., Zureik M. Antihypertensive drugs and COVID-19 risk: a cohort study of 2 million hypertensive patients. Hypertension. 2021;77:833&#x2013;842. doi: 10.1161/HYPERTENSIONAHA.120.16314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.16314</ArticleId><ArticleId IdType="pmc">PMC7884243</ArticleId><ArticleId IdType="pubmed">33423528</ArticleId></ArticleIdList></Reference><Reference><Citation>Senchenkova E.Y., Russell J., Almeida-Paula L.D., Harding J.W., Granger D.N. Angiotensin II-mediated microvascular thrombosis. Hypertension. 2010;56:1089&#x2013;1095. doi: 10.1161/HYPERTENSIONAHA.110.158220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.110.158220</ArticleId><ArticleId IdType="pmc">PMC3023299</ArticleId><ArticleId IdType="pubmed">20975035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N., Anders H.J., Gaikwad A.B. Fiend and friend in the renin angiotensin system: an insight on acute kidney injury. Biomed. Pharmacother. 2019 doi: 10.1016/j.biopha.2018.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.12.018</ArticleId><ArticleId IdType="pubmed">30554115</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X.Z., Okwan-Duodu D., Blackwell W.L., Ong F.S., Janjulia T., Bernstein E.A., Fuchs S., Alkan S., Bernstein K.E. Myeloid expression of angiotensin-converting enzyme facilitates myeloid maturation and inhibits the development of myeloid-derived suppressor cells. Lab. Invest. 2014;94:536&#x2013;544. doi: 10.1038/labinvest.2014.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2014.41</ArticleId><ArticleId IdType="pmc">PMC4221240</ArticleId><ArticleId IdType="pubmed">24614194</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenoy V., Gjymishka A., Jarajapu Y.P., Qi Y., Afzal A., Rigatto K., Ferreira A.J., Fraga-Silva R.A., Kearns P., Douglas J.Y., Agarwal D., Mubarak K.K., Bradford C., Kennedy W.R., Jun J.Y., Rathinasabapathy A., Bruce E., Gupta D., Cardounel A.J., Mocco J., Patel J.M., Francis J., Grant M.B., Katovich M.J., Raizada M.K. Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. Am. J. Respir. Crit. Care Med. 2013;187:648&#x2013;657. doi: 10.1164/rccm.201205-0880OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201205-0880OC</ArticleId><ArticleId IdType="pmc">PMC3733435</ArticleId><ArticleId IdType="pubmed">23370913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf5;es E Silva A.C., Silveira K.D., Ferreira A.J., Teixeira M.M. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br. J. Pharmacol. 2013 doi: 10.1111/bph.12159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12159</ArticleId><ArticleId IdType="pmc">PMC3682698</ArticleId><ArticleId IdType="pubmed">23488800</ArticleId></ArticleIdList></Reference><Reference><Citation>Skidgel R.A., Erd&#xf6;s E.G. The broad substrate specificity of human angiotensin i converting enzyme. Clin. Exp. Hypertens. A9. 1987:243&#x2013;259. doi: 10.3109/10641968709164184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10641968709164184</ArticleId><ArticleId IdType="pubmed">2440624</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodhi C.P., Wohlford-Lenane C., Yamaguchi Y., Prindle T., Fulton W.B., Wang S., McCray P.B., Chappell M., Hackam D.J., Jia H. Attenuation of pulmonary ACE2 activity impairs inactivation of des-arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration. Am. J. Physiol. Lung Cell Mol. Physiol. 2018;314:L17&#x2013;L31. doi: 10.1152/ajplung.00498.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00498.2016</ArticleId><ArticleId IdType="pmc">PMC5866432</ArticleId><ArticleId IdType="pubmed">28935640</ArticleId></ArticleIdList></Reference><Reference><Citation>Soler M.J., Wysocki J., Ye M., Lloveras J., Kanwar Y., Batlle D. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int. 2007;72:614&#x2013;623. doi: 10.1038/sj.ki.5002373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002373</ArticleId><ArticleId IdType="pubmed">17579661</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W., Gui M., Wang X., Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. 2018;14 doi: 10.1371/journal.ppat.1007236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007236</ArticleId><ArticleId IdType="pmc">PMC6107290</ArticleId><ArticleId IdType="pubmed">30102747</ArticleId></ArticleIdList></Reference><Reference><Citation>Soro-Paavonen A., Gordin D., Forsblom C., Rosengard-Barlund M., Waden J., Thorn L., Sandholm N., Thomas M.C., Groop P.H. Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J. Hypertens. 2012;30:375&#x2013;383. doi: 10.1097/HJH.0b013e32834f04b6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0b013e32834f04b6</ArticleId><ArticleId IdType="pubmed">22179088</ArticleId></ArticleIdList></Reference><Reference><Citation>Su J.B. Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems. JRAAS - J. Renin-Angiotensin-Aldosterone Syst. 2014 doi: 10.1177/1470320312474854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320312474854</ArticleId><ArticleId IdType="pubmed">23386283</ArticleId></ArticleIdList></Reference><Reference><Citation>Sul J.W., Kim T.Y., Yoo H.J., Kim J., Suh Y.A., Hwang J.J., Koh J.Y. A novel mechanism for the pyruvate protection against zinc-induced cytotoxicity: mediation by the chelating effect of citrate and isocitrate. Arch Pharm. Res. (Seoul) 2016;39:1151&#x2013;1159. doi: 10.1007/s12272-016-0814-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12272-016-0814-9</ArticleId><ArticleId IdType="pubmed">27515054</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryadevara N., Shrihari S., Gilchuk P., VanBlargan L.A., Binshtein E., Zost S.J., Nargi R.S., Sutton R.E., Winkler E.S., Chen E.C., Fouch M.E., Davidson E., Doranz B.J., Chen R.E., Shi P.Y., Carnahan R.H., Thackray L.B., Diamond M.S., Crowe J.E. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell. 2021;184:2316&#x2013;2331. doi: 10.1016/j.cell.2021.03.029. e15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.029</ArticleId><ArticleId IdType="pmc">PMC7962591</ArticleId><ArticleId IdType="pubmed">33773105</ArticleId></ArticleIdList></Reference><Reference><Citation>Suter F., Consolaro E., Pedroni S., Moroni C., Past&#xf2; E., Paganini M.V., Pravettoni G., Cantarelli U., Rubis N., Perico N., Perna A., Peracchi T., Ruggenenti P., Remuzzi G. A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: a retrospective observational matched-cohort study. EClinicalMedicine. 2021 doi: 10.1016/j.eclinm.2021.100941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100941</ArticleId><ArticleId IdType="pmc">PMC8189543</ArticleId><ArticleId IdType="pubmed">34127959</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S., Yoshiya T., Yoshizawa-Kumagaye K., Sugiyama T. Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean. Biomed. Res. 2015;36:219&#x2013;224. doi: 10.2220/biomedres.36.219.</Citation><ArticleIdList><ArticleId IdType="doi">10.2220/biomedres.36.219</ArticleId><ArticleId IdType="pubmed">26106051</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson E.C., Rosen L.E., Shepherd J.G., Spreafico R., da Silva Filipe A., Wojcechowskyj J.A., Davis C., Piccoli L., Pascall D.J., Dillen J., Lytras S., Czudnochowski N., Shah R., Meury M., Jesudason N., De Marco A., Li K., Bassi J., O&#x2019;Toole A., Pinto D., Colquhoun R.M., Culap K., Jackson B., Zatta F., Rambaut A., Jaconi S., Sreenu V.B., Nix J., Zhang I., Jarrett R.F., Glass W.G., Beltramello M., Nomikou K., Pizzuto M., Tong L., Cameroni E., Croll T.I., Johnson N., Di Iulio J., Wickenhagen A., Ceschi A., Harbison A.M., Mair D., Ferrari P., Smollett K., Sallusto F., Carmichael S., Garzoni C., Nichols J., Galli M., Hughes J., Riva A., Ho A., Schiuma M., Semple M.G., Openshaw P.J.M., Fadda E., Baillie J.K., Chodera J.D., Rihn S.J., Lycett S.J., Virgin H.W., Telenti A., Corti D., Robertson D.L., Snell G. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell. 2021;184:1171&#x2013;1187.e20. doi: 10.1016/j.cell.2021.01.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.037</ArticleId><ArticleId IdType="pmc">PMC7843029</ArticleId><ArticleId IdType="pubmed">33621484</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikellis C., Bialkowski K., Pete J., Sheehy K., Su Q., Johnston C., Cooper M.E., Thomas M.C. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes. 2008;57:1018&#x2013;1025. doi: 10.2337/db07-1212.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db07-1212</ArticleId><ArticleId IdType="pubmed">18235039</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobaiqy M., Elkout H., Maclure K. Analysis of thrombotic adverse reactions of covid-19 astrazeneca vaccine reported to eudravigilance database. Vaccines. 2021;9 doi: 10.3390/vaccines9040393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9040393</ArticleId><ArticleId IdType="pmc">PMC8074142</ArticleId><ArticleId IdType="pubmed">33923530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolouian R., Vahed S.Z., Ghiyasvand S., Tolouian A., Ardalan M. COVID-19 interactions with angiotensin-converting enzyme 2 (ACE2) and the kinin system; looking at a potential treatment. J. Ren. Inj. Prev. 2020;9 doi: 10.34172/jrip.2020.19. e19&#x2013;e19.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/jrip.2020.19</ArticleId></ArticleIdList></Reference><Reference><Citation>Towler P., Staker B., Prasad S.G., Menon S., Tang J., Parsons T., Ryan D., Fisher M., Williams D., Dales N.A., Patane M.A., Pantoliano M.W. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. 2004;279:17996&#x2013;18007. doi: 10.1074/jbc.M311191200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M311191200</ArticleId><ArticleId IdType="pmc">PMC7980034</ArticleId><ArticleId IdType="pubmed">14754895</ArticleId></ArticleIdList></Reference><Reference><Citation>Trask A.J., Groban L., Westwood B.M., Varagic J., Ganten D., Gallagher P.E., Chappell M.C., Ferrario C.M. Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in ren-2 hypertensive rats. Am. J. Hypertens. 2010;23:687&#x2013;693. doi: 10.1038/ajh.2010.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2010.51</ArticleId><ArticleId IdType="pmc">PMC3739444</ArticleId><ArticleId IdType="pubmed">20300067</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner A.J. ACE2 cell biology, regulation, and physiological functions. Prot. Arm Renin Angiotensin Syst. Funct. Asp. Ther. Implic. 2015:185&#x2013;189. doi: 10.1016/B978-0-12-801364-9.00025-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-801364-9.00025-0</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xda;ri K., Fagyas M., Siket I.M., Kert&#xe9;sz A., Csan&#xe1;di Z., S&#xe1;ndorfi G., Clemens M., Fedor R., Papp Z., &#xc9;des I., T&#xf3;th A., Lizanecz E. New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. PloS One. 2014;9 doi: 10.1371/journal.pone.0087845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087845</ArticleId><ArticleId IdType="pmc">PMC3972189</ArticleId><ArticleId IdType="pubmed">24691269</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xda;ri K., Fagyas M., Kert&#xe9;sz A., Borb&#xe9;ly A., Jenei C., Bene O., Csan&#xe1;di Z., Paulus W.J., &#xc9;des I., Papp Z., T&#xf3;th A., Lizanecz E. Circulating ACE2 activity correlates with cardiovascular disease development. JRAAS - J. Renin-Angiotensin-Aldosterone Syst. 2016;17 doi: 10.1177/1470320316668435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320316668435</ArticleId><ArticleId IdType="pmc">PMC5843890</ArticleId><ArticleId IdType="pubmed">27965422</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A., Solomon S.D. Renin&#x2013;angiotensin&#x2013;aldosterone system inhibitors in patients with covid-19. N. Engl. J. Med. 2020;382:1653&#x2013;1659. doi: 10.1056/nejmsr2005760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmsr2005760</ArticleId><ArticleId IdType="pmc">PMC7121452</ArticleId><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaidya A., Williams J.S. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism. 2012 doi: 10.1016/j.metabol.2011.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2011.09.007</ArticleId><ArticleId IdType="pmc">PMC3290690</ArticleId><ArticleId IdType="pubmed">22075270</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Veerdonk F.L., Netea M.G., van Deuren M., van der Meer J.W.M., de Mast Q., Br&#xfc;ggemann R.J., van der Hoeven H. Kallikrein-kinin blockade in patients with covid-19 to prevent acute respiratory distress syndrome. Elife. 2020;9 doi: 10.7554/ELIFE.57555.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/ELIFE.57555</ArticleId><ArticleId IdType="pmc">PMC7213974</ArticleId><ArticleId IdType="pubmed">32338605</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan D.E., Lazos S.A., Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells: a potential link between the renin-angiotensin system and thrombosis. J. Clin. Invest. 1995;95:995&#x2013;1001. doi: 10.1172/JCI117809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI117809</ArticleId><ArticleId IdType="pmc">PMC441432</ArticleId><ArticleId IdType="pubmed">7884001</ArticleId></ArticleIdList></Reference><Reference><Citation>Velez J.C.Q., Ierardi J.L., Bland A.M., Morinelli T.A., Arthur J.M., Raymond J.R., Janech M.G. Enzymatic processing of angiotensin peptides by human glomerular endothelial cells. Am. J. Physiol. Ren. Physiol. 2012;302 doi: 10.1152/ajprenal.00087.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00087.2012</ArticleId><ArticleId IdType="pmc">PMC3378096</ArticleId><ArticleId IdType="pubmed">22461301</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., Acton S., Patane M., Nichols A., Tummino P. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 2002;277:14838&#x2013;14843. doi: 10.1074/jbc.M200581200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200581200</ArticleId><ArticleId IdType="pubmed">11815627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallentin L., Lindb&#xe4;ck J., Eriksson N., Hijazi Z., Eikelboom J.W., Ezekowitz M.D., Granger C.B., Lopes R.D., Yusuf S., Oldgren J., Siegbahn A. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. Eur. Heart J. 2020;41:4037&#x2013;4046. doi: 10.1093/eurheartj/ehaa697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa697</ArticleId><ArticleId IdType="pmc">PMC7543499</ArticleId><ArticleId IdType="pubmed">32984892</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters T.E., Kalman J.M., Patel S.K., Mearns M., Velkoska E., Burrell L.M. Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. Europace. 2017;19:1280&#x2013;1287. doi: 10.1093/europace/euw246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euw246</ArticleId><ArticleId IdType="pubmed">27738071</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie F., Zhang X., Xie L. Prognostic value of serum zinc levels in patients with acute HC/zinc chloride smoke inhalation. Med. Times. 2017;96 doi: 10.1097/MD.0000000000008156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000008156</ArticleId><ArticleId IdType="pmc">PMC5626303</ArticleId><ArticleId IdType="pubmed">28953660</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P., Sriramula S., Lazartigues E. ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011 doi: 10.1152/ajpregu.00222.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00222.2010</ArticleId><ArticleId IdType="pmc">PMC3075080</ArticleId><ArticleId IdType="pubmed">21178125</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue J., Moyer A., Peng B., Wu J., Hannafon B.N., Ding W.Q. Chloroquine is a zinc ionophore. PloS One. 2014;9 doi: 10.1371/journal.pone.0109180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0109180</ArticleId><ArticleId IdType="pmc">PMC4182877</ArticleId><ArticleId IdType="pubmed">25271834</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagisawa M., Foster P.J., Hanaki H., &#x14c;mura S. 2021. Global Trends in Clinical Studies of Ivermectin in COVID-19.</Citation></Reference><Reference><Citation>Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444&#x2013;1448. doi: 10.1126/science.abb2762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G., Tan Z., Zhou L., Yang M., Peng L., Liu J., Cai J., Yang R., Han J., Huang Y., He S. Effects of angiotensin II receptor blockers and ACE (Angiotensin-Converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study. Hypertension. 2020;76:51&#x2013;58. doi: 10.1161/HYPERTENSIONAHA.120.15143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15143</ArticleId><ArticleId IdType="pubmed">32348166</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaseen M.M., Abuharfeil N.M., Darmani H., Daoud A. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine. Open Biol. 2020 doi: 10.1098/rsob.200111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200111</ArticleId><ArticleId IdType="pmc">PMC7536076</ArticleId><ArticleId IdType="pubmed">32931721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye M., Wysocki J., Gonzalez-Pacheco F.R., Salem M., Evora K., Garcia-Halpin L., Poglitsch M., Schuster M., Batlle D. Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2. Hypertension. 2012;60:730&#x2013;740. doi: 10.1161/HYPERTENSIONAHA.112.198622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.112.198622</ArticleId><ArticleId IdType="pmc">PMC3426447</ArticleId><ArticleId IdType="pubmed">22777933</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung M.L., Teng J.L.L., Jia L., Zhang C., Huang C., Cai J.P., Zhou R., Chan K.H., Zhao H., Zhu L., Siu K.L., Fung S.Y., Yung S., Chan T.M., To K.K.W., Chan J.F.W., Cai Z., Lau S.K.P., Chen Z., Jin D.Y., Woo P.C.Y., Yuen K.Y. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Cell. 2021;184:2212&#x2013;2228. doi: 10.1016/j.cell.2021.02.053. e12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.053</ArticleId><ArticleId IdType="pmc">PMC7923941</ArticleId><ArticleId IdType="pubmed">33713620</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.M., Wong R.S.M., Wu E.B., Kong S.L., Wong J., Yip G.W.K., Soo Y.O.Y., Chiu M.L.S., Chan Y.S., Hui D., Lee N., Wu A., Leung C.B., Sung J.J.Y. Cardiovascular complications of severe acute respiratory syndrome. Postgrad. Med. 2006;82:140&#x2013;144. doi: 10.1136/pgmj.2005.037515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2005.037515</ArticleId><ArticleId IdType="pmc">PMC2596695</ArticleId><ArticleId IdType="pubmed">16461478</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y., Cao D., Zhang Y., Ma J., Qi J., Wang Q., Lu G., Wu Y., Yan J., Shi Y., Zhang X., Gao G.F. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat. Commun. 2017;8 doi: 10.1038/ncomms15092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15092</ArticleId><ArticleId IdType="pmc">PMC5394239</ArticleId><ArticleId IdType="pubmed">28393837</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S., Wang R., Chan J.F.W., Zhang A.J., Cheng T., Chik K.K.H., Ye Z.W., Wang S., Lee A.C.Y., Jin L., Li H., Jin D.Y., Yuen K.Y., Sun H. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters. Nat. Microbiol. 2020;5:1439&#x2013;1448. doi: 10.1038/s41564-020-00802-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00802-x</ArticleId><ArticleId IdType="pubmed">33028965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamai L. The yin and Yang of ACE/ACE2 pathways: the rationale for the use of renin-angiotensin system inhibitors in COVID-19 patients. Cells. 2020 doi: 10.3390/cells9071704.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071704</ArticleId><ArticleId IdType="pmc">PMC7408073</ArticleId><ArticleId IdType="pubmed">32708755</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamai L. Unveiling human non-random genome editing mechanisms activated in response to chronic environmental changes: I. Where might these mechanisms come from and what might they have led to? Cells. 2020 doi: 10.3390/cells9112362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112362</ArticleId><ArticleId IdType="pmc">PMC7693803</ArticleId><ArticleId IdType="pubmed">33121045</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamai L. Upregulation of the renin-angiotensin system pathways and SARS-CoV-2 infection: the rationale for the administration of zinc-chelating agents in COVID-19 patients. Cells. 2021;10:506. doi: 10.3390/cells10030506.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030506</ArticleId><ArticleId IdType="pmc">PMC7997276</ArticleId><ArticleId IdType="pubmed">33673459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamai L., Rocchi M.B.L. Hypothesis: possible influence of antivector immunity and SARS-CoV-2 variants on efficacy of ChAdOx1 nCoV-19 vaccine. Br. J. Pharmacol. bph. 2021;15620 doi: 10.1111/BPH.15620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/BPH.15620</ArticleId><ArticleId IdType="pmc">PMC8444749</ArticleId><ArticleId IdType="pubmed">34331459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanza C., Racca F., Longhitano Y., Piccioni A., Franceschi F., Artico M., Abenavoli L., Maiese A., Passaro G., Volonnino G., Russa R. La. Risk management and treatment of coagulation disorders related to COVID-19 infection. Int. J. Environ. Res. Publ. Health. 2021 doi: 10.3390/ijerph18031268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18031268</ArticleId><ArticleId IdType="pmc">PMC7908596</ArticleId><ArticleId IdType="pubmed">33572570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Liu Y., Wang X., Yang L., Li H., Wang Y., Liu M., Zhao X., Xie Y., Yang Y., Zhang Shenghui, Fan Z., Dong J., Yuan Z., Ding Z., Zhang Y., Hu L. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J. Hematol. Oncol. 2020;13 doi: 10.1186/s13045-020-00954-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Wu Y., Zhao M., Liu C., Zhou L., Shen S., Liao S., Yang K., Li Q., Wan H. Role of HIF-1&#x3b1; in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2009;297 doi: 10.1152/ajplung.90415.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.90415.2008</ArticleId><ArticleId IdType="pubmed">19592460</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Xue, Yu J., Pan L., ya Jiang H.yin. ACEI/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis. Pharmacol. Res. 2020 doi: 10.1016/j.phrs.2020.104927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104927</ArticleId><ArticleId IdType="pmc">PMC7227582</ArticleId><ArticleId IdType="pubmed">32422341</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Xiaoqing, Zhang X., Li S., Niu S. ACE2 and COVID-19 and the resulting ARDS. Postgrad. Med. 2020 doi: 10.1136/postgradmedj-2020-137935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-137935</ArticleId><ArticleId IdType="pmc">PMC10016912</ArticleId><ArticleId IdType="pubmed">32522846</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Zhu L., Cai J., Lei F., Qin J.J., Xie J., Liu Y.M., Zhao Y.C., Huang Xuewei, Lin L., Xia M., Chen M.M., Cheng X., Zhang X., Guo D., Peng Y., Ji Y.X., Chen J., She Z.G., Wang Y., Xu Q., Tan R., Wang H., Lin J., Luo P., Fu S., Cai H., Ye P., Xiao B., Mao W., Liu L., Yan Y., Liu M., Chen M., Zhang X.J., Wang X., Touyz R.M., Xia J., Zhang B.H., Huang Xiaodong, Yuan Y., Rohit L., Liu P.P., Li H. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ. Res. 2020;126:1671&#x2013;1681. doi: 10.1161/CIRCRESAHA.120.317134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317134</ArticleId><ArticleId IdType="pmc">PMC7265882</ArticleId><ArticleId IdType="pubmed">32302265</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Qin L., Zhang P., Li K., Liang L., Sun J., Xu B., Dai Y., Li X., Zhang C., Peng Y., Feng Y., Li A., Hu Z., Xiang H., Ogg G., Ho L.P., McMichael A., Jin R., Knight J.C., Dong T., Zhang Y. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. 2020;5 doi: 10.1172/jci.insight.139834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.139834</ArticleId><ArticleId IdType="pmc">PMC7406242</ArticleId><ArticleId IdType="pubmed">32501293</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Chen Y., Zhang Shuyuan, Niu P., Qin K., Jia W., Huang B., Zhang Senyan, Lan J., Zhang L., Tan W., Wang X. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein. Nat. Commun. 2019;10 doi: 10.1038/s41467-019-10897-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10897-4</ArticleId><ArticleId IdType="pmc">PMC6624210</ArticleId><ArticleId IdType="pubmed">31296843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler C.G.K., Allon S.J., Nyquist S.K., Mbano I.M., Miao V.N., Tzouanas C.N., Cao Y., Yousif A.S., Bals J., Hauser B.M., Feldman J., Muus C., Wadsworth M.H., Kazer S.W., Hughes T.K., Doran B., Gatter G.J., Vukovic M., Taliaferro F., Mead B.E., Guo Z., Wang J.P., Gras D., Plaisant M., Ansari M., Angelidis I., Adler H., Sucre J.M.S., Taylor C.J., Lin B., Waghray A., Mitsialis V., Dwyer D.F., Buchheit K.M., Boyce J.A., Barrett N.A., Laidlaw T.M., Carroll S.L., Colonna L., Tkachev V., Peterson C.W., Yu A., Zheng H.B., Gideon H.P., Winchell C.G., Lin P.L., Bingle C.D., Snapper S.B., Kropski J.A., Theis F.J., Schiller H.B., Zaragosi L.E., Barbry P., Leslie A., Kiem H.P., Flynn J.A.L., Fortune S.M., Berger B., Finberg R.W., Kean L.S., Garber M., Schmidt A.G., Lingwood D., Shalek A.K., Ordovas-Montanes J., Banovich N., Brazma A., Desai T., Duong T.E., Eickelberg O., Falk C., Farzan M., Glass I., Haniffa M., Horvath P., Hung D., Kaminski N., Krasnow M., Kuhnemund M., Lafyatis R., Lee H., Leroy S., Linnarson S., Lundeberg J., Meyer K., Misharin A., Nawijn M., Nikolic M.Z., Pe&#x2019;er D., Powell J., Quake S., Rajagopal J., Tata P.R., Rawlins E.L., Regev A., Reyfman P.A., Rojas M., Rosen O., Saeb-Parsy K., Samakovlis C., Schiller H., Schultze J.L., Seibold M.A., Shepherd D., Spence J., Spira A., Sun X., Teichmann S., Theis F., Tsankov A., van den Berge M., von Papen M., Whitsett J., Xavier R., Xu Y., Zhang K. Kinins and chymase: The forgotten components of the renin-angiotensin system and their implications in COVID-19 disease. Am. J. Physiol. - Lung Cell. Mol. Physiol. 2021 doi: 10.1152/AJPLUNG.00548.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/AJPLUNG.00548.2020</ArticleId><ArticleId IdType="pmc">PMC7938643</ArticleId><ArticleId IdType="pubmed">33404363</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoufaly A., Poglitsch M., Aberle J.H., Hoepler W., Seitz T., Traugott M., Grieb A., Pawelka E., Laferl H., Wenisch C., Neuhold S., Haider D., Stiasny K., Bergthaler A., Puchhammer-Stoeckl E., Mirazimi A., Montserrat N., Zhang H., Slutsky A.S., Penninger J.M. Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir. Med. 2020;8:1154&#x2013;1158. doi: 10.1016/S2213-2600(20)30418-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30418-5</ArticleId><ArticleId IdType="pmc">PMC7515587</ArticleId><ArticleId IdType="pubmed">33131609</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>